lamivudine has been researched along with Recrudescence in 276 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 31 (11.23) | 18.2507 |
| 2000's | 188 (68.12) | 29.6817 |
| 2010's | 55 (19.93) | 24.3611 |
| 2020's | 2 (0.72) | 2.80 |
| Authors | Studies |
|---|---|
| Giannini, EG; Lai, Q | 1 |
| Roche, B; Samuel, D | 3 |
| Allweiss, L; Beninati, C; Dandri, M; Giersch, K; Kah, J; Lohse, AW; Lütgehetmann, M; Petersen, J; Pollicino, T; Raffa, G; Urban, S; Volz, T | 1 |
| Gane, EJ | 1 |
| Chan, A; Cheung, TT; Chok, K; Dai, WC; Fung, J; Lai, CL; Lo, CM; Man, K; Ng, K; Seto, WK; Sin, SL; Wong, T; Yuen, MF | 1 |
| Hagiwara, S; Ida, H; Komeda, Y; Kudo, M; Nishida, N; Nishijima, N; Osaki, Y; Sakurai, T; Takita, M; Ueshima, K; Watanabe, T | 1 |
| Chen, YM; Deng, H; Gao, ZL; Lin, CS; Mei, YY; Peng, L; Xie, C; Xie, DY; Xu, WX; Zhang, Q; Zhao, ZX; Zhu, X | 1 |
| Alteri, C; Andreoni, M; Angelico, M; Cento, V; De Sanctis, GM; Gubertini, G; Micheli, V; Parruti, G; Perno, CF; Pollicita, M; Romano, S; Salpini, R; Sarrecchia, C; Svicher, V; Visca, M | 1 |
| Chen, Q; He, LL; Wang, JC | 1 |
| Chan, HL; Chan, HY; Chim, AM; Lo, AO; Tse, CH; Wong, GL; Wong, VW | 1 |
| Fang, J; Li, D; Li, W; Tan, Z | 1 |
| Goyal, N; Gupta, S; Kumar, A; Taneja, S; Wadhawan, M | 1 |
| Changchien, CS; Chen, CH; Hu, TH; Hung, CH; Lee, CM; Lu, SN; Wang, JH | 1 |
| Afdhal, NH; Bonder, A; Lau, D; Patwardhan, VR; Sengupta, N | 1 |
| Cao, H; Han, J; Jiao, Z; Zhang, D | 1 |
| Hwang, JH; Jang, ES; Jeong, SH; Kim, JW; Kim, N; Lee, DH; Lee, SS; Min, BY; Park, YS; Seong, MH; Shin, CM; Sohn, HR; Song, JC | 1 |
| Calise, F; Cuomo, O; DiCostanzo, G; Lanza, AG; Perrella, A; Pisaniello, D | 1 |
| Fen, L | 1 |
| Jiao, Z; Yan, L; Zhang, D | 1 |
| Changchien, CS; Chen, CH; Hsu, MC; Hu, TH; Hung, CH; Lee, CM; Lu, SN; Wang, JH; Yao, CC | 1 |
| Choudhary, NS; Goja, S; Menon, PB; Mohanka, R; Rastogi, A; Saigal, S; Saraf, N; Soin, AS | 1 |
| Akarca, US; Bademkiran, F; Duman, S; Ersoz, G; Gunsar, F; Karasu, Z; Kose, T; Ozutemiz, O; Sozbilen, M; Turan, I; Yapali, S | 1 |
| Ahmadinejad, Z; Dashti, H; Jafarian, A; Kasraianfard, A; Moini, M; Najafi, A; Nassiri-Toosi, M; Salimi, J | 1 |
| Fong, TL; Hsieh, MJ; Khemichian, S; Kim, J; Limurti, J; Zhang, SR | 1 |
| Chen, CR; Chen, L; Huang, HJ; Pan, HY; Tong, YX; Yan, J; Yang, DH | 1 |
| Choi, GH; Choi, JS; Joo, DJ; Ju, MK; Kim, MS; Kim, SI; Lee, J; Lee, JG; Lee, JJ; Song, SH | 1 |
| Fu, WD; He, LX; Jiang, JN; Li, SH; Liang, P; Liu, ZH; Lu, AL; Mo, YY; Su, MH; Wang, BJ; Wu, XL; Xie, R; Zhong, SH | 1 |
| Ahn, SH; Chon, YE; Han, KH; Jung, KS; Kang, W; Kim, BK; Kim, do Y; Kim, HS; Kim, SU; Park, JY | 1 |
| Ohdan, H; Onoe, T; Tahara, H; Tanaka, Y | 1 |
| Anzai, K; Arase, Y; Hirose, S; Kagawa, T; Mine, T; Nagata, N; Shiraishi, K; Tsuruya, K | 1 |
| Ahn, SH; Han, KH; Kim, BK; Kim, DY; Kim, MN; Kim, SU; Park, JY | 1 |
| Akyildiz, M; Balci, D; Cinar, K; Dayangac, M; Gungor, G; Hazinedaroglu, S; Idilman, R; Kalkan, C; Keskin, O; Tokat, Y; Yilmaz, TU | 1 |
| Chmura, A; Cieciura, T; Jonas, M; Małkowski, P; Wasiak, D; Łągiewska, B | 1 |
| Byun, KS; Jong Eun, Y; Jung, YK; Kang, K; Kang, SH; Kim, JH; Kim, TS; Lee, YS; Seo, YS; Suh, SJ; Yim, HJ; Yoo, YJ; Yoon, EL | 1 |
| Chen, SC; Chuang, WL; Dai, CY; Hsieh, MH; Hsieh, MY; Huang, CF; Huang, CI; Huang, JF; Lin, ZY; Yeh, ML; Yu, ML | 1 |
| Akarca, US; Buster, EH; Cakaloglu, Y; Feinman, SV; Flink, HJ; Hansen, BE; Janssen, HL; Mach, T; Schutten, M; Simon, K; So, TM; Tabak, F; Tielemans, W; Trojan, J; van Vuuren, AJ | 1 |
| Barraud, H; Bronowicki, JP; Cadranel, JF; Nani, A | 1 |
| Bellini, C; Bernasconi, E; Cavassini, M; Chave, JP; Evison, J; Fehr, J; Kaiser, L; Keiser, O; Telenti, A; Vernazza, P; Weber, R | 1 |
| Bacq, Y; Baty, G; de Muret, A; Dubois, F; Negreanu, L | 1 |
| Akay, S; Karasu, Z | 1 |
| Cai, CJ; Chen, GH; Jiang, H; Jiang, N; Li, H; Li, X; Lu, MQ; Wang, GS; Xu, C; Yang, Q; Yang, Y; Yi, HM; Yi, SH; Zhang, J; Zhang, JF | 1 |
| Bak, YT; Byun, KS; Choi, JH; Joo, MK; Jung, YK; Kim, CH; Kim, JH; Kim, JS; Lee, SJ; Park, JJ; Yeon, JE; Yim, HJ | 1 |
| Brett-Smith, H; Carosi, G; Chang, TT; Cheinquer, H; Han, S; Kaymakoglu, S; Lai, CL; Martin, P; Shouval, D; Tamez, R; Tenney, D; Yang, J | 1 |
| Borup, C; Siboni, A | 1 |
| Degertekin, B; Lok, AS | 1 |
| Dorobantu, B; Gangone, E; Gheorghe, L; Hrehoret, D; Iacob, S; Matei, E; Popescu, I | 1 |
| Akuta, N; Arase, Y; Hosaka, T; Ikeda, K; Kawamura, Y; Kobayashi, M; Kumada, H; Miyakawa, Y; Saitoh, S; Sezaki, H; Suzuki, F; Suzuki, Y; Yatsuji, H | 1 |
| Choi, MS; Jung, HW; Kim, KH; Koh, KC; Lee, JH; Paik, SW; Park, SH; Yeon, KK; Yoo, BC | 1 |
| Chiba, T; Ichinohe, T; Kadowaki, N; Marusawa, H; Uchiyama, T; Ueda, Y | 1 |
| García-Lázaro, M; Natera, C; Rivero, A; Villar, C | 1 |
| Chen, YC; Hsu, CW; Liaw, YF; Yeh, CT | 1 |
| Gao, DM; Guo, QL; Li, N; Liu, Y; Lu, SC; Wang, ML; Wu, JS; Xia, RP; Zhang, Y | 1 |
| Li, XY; Liu, F; Liu, YD; Wang, JB; Wang, L; Wang, YZ; Zhang, ZH | 2 |
| Changchien, CS; Chen, CH; Hung, CH; Kuo, YH; Lee, CM; Lu, SN; Tseng, PL; Wang, JH | 1 |
| Burroughs, AK; Cholongitas, E; Papatheodoridis, GV | 1 |
| Babiker, AG; Darbyshire, JH; Gibb, DM; Gilks, CF; Grosskurth, H; Kityo, C; Mugyenyi, P; Munderi, P; Reid, A; Ssali, F; Walker, AS | 1 |
| Jiang, L; Yan, LN | 1 |
| Ahn, SH; Chon, CY; Han, KH; Kim, DY; Kim, JK; Lee, KS; Paik, YH; Park, JY | 1 |
| Alavian, SM; Fallahian, F; Fallahian, V; Zamani, F | 1 |
| Chun, J; Kim, BG; Kim, W; Kim, YJ; Lee, HS; Lee, KL; Park, KU; Suh, KS; Yi, NJ; Yoon, JH | 1 |
| Boucher, CA; Hansen, BE; Janssen, HL; Rijckborst, V; Sonneveld, MJ | 1 |
| Cho, HC; Choi, MS; Gwak, GY; Kim, KH; Koh, KC; Lee, JH; Lee, YY; Paik, SW; Sinn, DH; Yoo, BC; Yun, WK | 1 |
| Fung, J; Lai, CL; Yuen, MF | 1 |
| Kawano, K; Nampei, A; Shi, K; Takeuchi, E; Tsuboi, H; Tsujii, A; Yoshihara, H | 1 |
| Chan, HL; Ge, S; Guo, W; Hu, J; Huang, X; Jiang, J; Jiang, Z; Liang, Y; Liu, Z; Su, M; Wong, VW; Xie, R; Zhu, M | 1 |
| Jiang, MD; Qin, JP; Wang, Z; Wu, XL; Xu, H; Zeng, WZ; Zhang, Y | 1 |
| Ahn, JH; Ahn, SH; Gong, G; Jung, KH; Kim, SB; Sohn, BS; Son, BH | 1 |
| Byun, KS; Jung, ES; Jung, YK; Kim, JH; Lee, KG; Ryu, HS; Seo, YS; Um, SH; Yeon, JE; Yim, HJ | 1 |
| Deng, YL; Gao, W; Jiang, WT; Qu, W; Rao, W; Shen, ZY; Sun, LY; Sun, XY; Zhang, JJ; Zhang, YM; Zhu, ZJ | 1 |
| Chung, YH; Jin, YJ; Kim, KM; Lee, HC; Lee, YS; Shim, JH; Suh, DJ; Yoo, DJ | 1 |
| Bae, SH; Choi, JY; Jang, JW; Kwon, JH; Park, CH; Yoo, SH; Yoon, SK | 1 |
| Han, SS; Hong, G; Kong, SY; Lee, KB; Lee, KW; Park, KU; Park, SJ; Suh, KS; Yi, NJ | 1 |
| Samuel, D | 2 |
| Chan, FK; Chan, HL; Chui, AK; Lau, WY; Rao, AR; Sung, JJ; Tse, CH; Wong, J; Wong, ML | 1 |
| Berg, T; Jonas, S; Müller, AR; Neuhaus, P; Neuhaus, R; Rayes, N; Seehofer, D; Settmacher, U; Steinmüller, T | 1 |
| Guan, R; Kajiji, T; Lim, SG; Rajnakova, A; Wai, CT | 1 |
| Berg, T; Müller, AR; Neuhaus, P; Neuhaus, R; Rayes, N; Seehofer, D; Steinmüller, T | 1 |
| Fischer, L; Meier, D; Rogiers, X; Sterneck, M; Zöllner, B | 1 |
| Engler, S; Kallinowski, B; Klar, E; Sauer, P; Stremmel, W | 1 |
| Hasegawa, K; Hashimoto, E; Hayashi, N; Iizuka, A; Ishikawa, K; Joh, R; Kanai, N; Naritomi, T; Ogawa, M; Shizuma, T; Torii, N | 1 |
| Terrault, NA | 1 |
| Hanada, S; Harada, M; Kaji, R; Kumashiro, R; Sata, M | 1 |
| Lau, GK; Liang, R; Lie, A | 1 |
| Chan, TM; Cheng, IK; Fang, GX; Ho, SK; Lai, KN; Tang, CS | 1 |
| Changchien, CS; Chen, TM; Lee, CM; Liao, CA; Lu, SN; Ong, GY; Tung, HD; Wang, JH | 1 |
| Alloway, RR; Bagous, T; Egidi, MF; Gaber, AO; Grewal, HP; Hardinger, KL; Honaker, MR; Kizilisik, AT; Shokouh-Amiri, MH; Stratta, RJ; Trofe, J; Vera, SR | 1 |
| Akuta, N; Arase, Y; Ikeda, K; Kobayashi, M; Kumada, H; Miyakawa, Y; Saitoh, S; Someya, T; Suzuki, F; Suzuki, Y; Tsubota, A | 1 |
| Koike, K | 1 |
| Broelsch, CE; Gerken, G; Karliova, M; Malago, M; Rothaar, T; Treichel, U; Trippler, M; Valentin-Gamazo, C | 1 |
| Barg-Hock, H; Becker, T; Bleck, JS; Bock, CT; Böker, KH; Flemming, P; Klempnauer, J; Manns, MP; Rosenau, J; Tillmann, HL; Trautwein, C | 1 |
| Berg, T; Hopf, U; Schernick, A; Van Bömmel, F | 1 |
| Baldanti, F; Galloni, D; Gerna, G; Lilleri, D; Piccinini, G; Seminari, E | 1 |
| Chan, HW; Tong, KL; Tsang, WK | 1 |
| Burroughs, AK; Papatheodoridis, GV; Sevastianos, V | 1 |
| Bar-Nathan, N; Ben-Ari, Z; Mor, E; Shaharabani, E; Shapira, Z; Tur-Kaspa, R | 1 |
| Bernardos, A; Cañas, E; Díaz, C; García, I; Gómez, MA; Hinojosa, R; Martín, C; Pareja, F; Pascasio, JM; Pérez-Bernal, JB; Sayago, M; Serrano, J; Sousa, JM; Tamayo, MJ | 1 |
| Ben-Ari, Z; Mor, E; Tur-Kaspa, R | 1 |
| Chrissafidou, A; Malek, M; Musch, E | 1 |
| Chroni, E; Karatza, CL; Papapetropoulos, S; Paschalis, C; Thomopoulos, C | 1 |
| Allwinn, R; Caspary, WF; Faust, D; Rabenau, HF; Zeuzem, S | 1 |
| Chang, FY; Chang, TT; Huang, YH; Huo, TI; Lee, PC; Lee, SD; Sheen, IJ; Su, CW; Wang, YJ; Wu, JC | 1 |
| Jeong, Id; Joo, KR; Kim, BC; Kim, DH; Park, JH; Park, NH; Seo, KW | 1 |
| Berger, F; Boillot, O; Chevallier, P; Dumortier, J; Scoazec, JY | 1 |
| Cai, C; Chen, G; He, X; Huang, J; Lu, M; Wang, G; Yang, Y; Zhu, X | 2 |
| Barcena Marugan, R; Cid Gomez, L; Lopez Serrano, P | 1 |
| Albeniz Arbizu, E; Barcena Marugan, R; de Vicente Lopez, E; Garcia Gonzalez, M; Mateo Lindeman, M; Moraleda Garcia, G; Oton Nieto, E | 1 |
| Albeniz Arbizu, E; Barcena Marugan, R; Carrera Alonso, E; de Vicente Lopez, E; Garcia Gonzalez, M; Martin Davila, P; Moreno Garcia, J; Nuño Vazquez-Garza, J; Oton Nieto, E | 1 |
| Choi, MH; Chung, YH; Jang, MK; Kim, JA; Lee, HC; Lee, YS; Park, NH; Ryu, SH; Shin, JW; Suh, DJ | 1 |
| Maier, KP | 1 |
| Keeffe, EB; Yu, AS | 1 |
| Bang, SJ; Joo, KR; Kim, DH; Park, JH; Park, NH; Shin, JW | 1 |
| Akuta, N; Arase, Y; Hosaka, T; Ikeda, K; Kobayashi, M; Kumada, H; Matsuda, M; Saitoh, S; Sato, J; Someya, T; Suzuki, F; Suzuki, Y; Takagi, K; Tsubota, A | 1 |
| Chien, RN; Chu, CM; Liaw, YF; Tsai, SL; Yeh, CT | 1 |
| Li, B; Li, XD; Lin, QY; Liu, C; Liu, J; Lu, SC; Ma, YK; Qing, S; Wang, XB; Wen, TF; Yan, LN; Zhang, XH; Zhao, JC; Zhao, LS | 1 |
| Beckebaum, S; Broelsch, CE; Cicinnati, VR; Gerken, G | 1 |
| Andriulli, A; Facciorusso, D; Fontana, R; Gioffreda, D; Guastadisegni, A; Insalata, M; Niro, GA; Palmieri, O; Pastore, G; Perri, F; Santantonio, T; Signorile, F | 1 |
| Chung, YH; Kim, H; Lee, HC; Lee, YS; Lim, YS; Ryu, SH; Shin, JW; Suh, DJ | 1 |
| De Diego, L; Martín, E; Martín, L; Martínez, MC; Rendón, P; Soria, MJ | 1 |
| Altmeyer, P; Boms, S; Gambichler, T; Paech, V; Rotterdam, S; Stücker, M | 1 |
| Hino, T; Hirashima, N; Ide, T; Ito, H; Ito, K; Kato, A; Kumashiro, R; Mizokami, M; Mukaide, M; Nukaya, H; Orito, E; Sakakibara, K; Sata, M; Tanaka, Y; Ueda, R | 1 |
| Durlik, M; Lao, M; Lewandowska, D; Lewandowski, Z; Pazik, J | 1 |
| Attili, A; Berloco, P; Callejon, V; Ferretti, G; Ferretti, S; Ginanni Corradini, S; Iappelli, M; Lilli, D; Mancini, C; Masini, A; Merli, M; Rivanera, D; Rossi, M; Tanzilli, P | 1 |
| Angelico, M; Di Paolo, D; Lenci, I; Piccolo, P; Tisone, G; Zazza, S | 1 |
| Chao, TY; Dai, MS; Kao, WY; Shyu, RY | 1 |
| Kagawa, T; Kanai, T; Kanouda, H; Kawazoe, K; Kumaki, N; Matsuzaki, S; Mine, T; Shiba, T; Shimamura, K; Takashimizu, S; Takayama, I; Watanabe, N | 1 |
| Ashur, Y; Ben-Ari, Z; Brown, M; Daudi, N; Klein, A; Mor, E; Shmilovitz-Wiess, H; Shouval, D; Sulkes, J; Tur-Kaspa, R | 1 |
| Trautwein, C | 1 |
| Barbon, V; Gaia, S; Lagget, M; Marzano, A; Rizzetto, M | 1 |
| Chao, TY; Dai, MS; Kao, WY; Liu, TM; Shyu, RY | 1 |
| Yokosuka, O | 1 |
| Fung, SK; Hussain, M; Lok, AS; Wong, F | 1 |
| Chan, AO; Lai, CL; Sablon, E; Wong, BC; Wong, DK; Yuan, HJ; Yuen, MF | 1 |
| Cooksley, WG | 1 |
| De Medina, M; Madariaga, J; Montalbano, M; Neff, GW; Nery, C; Nery, J; O'brien, CB; Ruiz, P; Safdar, K; Schiff, ER; Shire, N; Tzakis, AG | 1 |
| Chen, L; Lin, GL; Xiao, JS; Yang, SJ; Zhang, XH; Zhu, JY | 1 |
| Basso, M; Campo, N; Delfino, A; Martelli, A; Mattioli, F; Pelli, N; Picciotto, A; Torre, F | 1 |
| Chen, DS; Chen, PJ; Huang, WL; Kao, JH; Lai, MY; Liu, CJ | 1 |
| Da Costa, M; Dan, YY; Isaac, J; Lee, HL; Lee, KH; Lee, YM; Lim, SG; Mak, K; Prabhakaran, K; Sutedja, DS; Wai, CT; Wee, A | 1 |
| Cotler, SJ; Mohanty, SR | 1 |
| Ali, H; Egawa, H; Kasahara, M; Marusawa, H; Nabeshima, M; Ogawa, K; Tanaka, K; Ueda, M; Uryuhara, K | 1 |
| Akay, S; Akyildiz, M; Karasu, Z; Tokat, Y | 1 |
| Caccamo, L; Colombo, M; Fassati, LR; Lunghi, G; Maggioni, M; Radice, F; Romeo, R; Rossi, G | 1 |
| Husa, P | 1 |
| Trunecka, P | 1 |
| Akuta, N; Arase, Y; Hosaka, T; Ikeda, K; Kobayashi, M; Kumada, H; Saitoh, S; Sezaki, H; Someya, T; Suzuki, F; Suzuki, Y; Tsubota, A | 1 |
| Alessandria, C; Carenzi, S; Debernardi-Venon, W; Franchello, A; Gaia, S; Ghisetti, V; Marzano, A; Premoli, A; Rizzetto, M; Salizzoni, M | 1 |
| Ahn, CS; Ha, TY; Hwang, S; Kim, KH; Kim, KK; Lee, SG; Moon, DB | 1 |
| Cho, YS; Chon, CY; Han, KH; Lee, CK; Moon, YM; Park, IS; Suh, JH; Won, SY | 1 |
| Akuta, N; Arase, Y; Hosaka, T; Ikeda, K; Kobayashi, M; Kumada, H; Matsuda, M; Saitoh, S; Sato, J; Sezaki, H; Someya, T; Suzuki, F; Suzuki, Y | 1 |
| Cuadrado, JM; Jover, F; Martínez-Baltanás, A; Roig, P | 1 |
| Chan, HL; Chim, AM; Hui, AY; Sung, JJ; Wong, ML; Wong, VW | 1 |
| Andreoli, A; Bandelier, C; Bianchi-Demicheli, F; Damsa, C; Lazignac, C; Maris, S; Vidailhet, P | 1 |
| von Weizsäcker, F | 1 |
| de Man, RA; Flink, HJ; Hansen, BE; Janssen, HL; Schalm, SW; Sprengers, D; van Zonneveld, M | 1 |
| Bang, SJ; Jeong, ID; Joo, KR; Kim, DH; Park, JH; Park, NH; Shin, JW | 1 |
| Bellido, D; Casado, JL; Chamorro, AJ; Moreno, S | 1 |
| Bae, SH; Choi, JY; Choi, SW; Chung, KW; Jang, JW; Kim, BS; Kim, CW; Lee, CD; Lee, YS; Sun, HS; Yoon, SK | 1 |
| Asahina, Y; Enomoto, N; Izumi, N; Kitamura, T; Kurosaki, M; Miyake, S; Nakanishi, H; Nishimura, Y; Onuki, Y; Tsuchiya, K; Uchihara, M; Ueda, K | 1 |
| Guan, R | 1 |
| Lau, GK | 1 |
| Alexander, G; Baba, CS; Chetri, K; Choudhuri, G; Negi, TS | 1 |
| Su, GG; Ying, MF; Zhao, NF; Zhou, Y | 1 |
| Balaska, A; Doukelis, P; Eugenidis, NP; Giouleme, OI; Grammatikos, N; Nikolaidis, NL; Orfanou-Koumerkeridou, E; Patsiaoura, K; Saveriadis, AS; Tziomalos, KA; Vassiliadis, T; Voutsas, AD | 1 |
| Shen, ZY; Wang, ZF; Zhu, ZJ | 1 |
| Berg, T; Seehofer, D | 1 |
| Colombo, M; Cortelezzi, A; Deliliers, GL; Fantini, NN; Lampertico, P; Pasquini, MC; Viganò, M; Zilioli, VR | 1 |
| Bak, YT; Byun, KS; Chang, YJ; Kim, JH; Kim, JS; Kim, JY; Kwon, OS; Lee, CH; Park, JJ; Yeon, JE; Yim, HJ | 1 |
| Bradarić, N | 1 |
| Avilés, JF; Bárcena, R; Barrios, C; Buti, M; Casanovas, T; Cuervas, V; De la Mata, M; Del Campo, S; Delgado, M; Dieguez, ML; Fraga, E; Gonzalez, A; Herrero, JI; Loinaz, C; Mas, A; Moraleda, G; Moreno, JM; Muñoz, R; Otero, A; Prieto, M; Rueda, M; Sousa, JM | 1 |
| Barcena, R; Blesa, C; Foruny, JR; Garcia-Garzon, S; Garcia-Gonzalez, M; Moreno, A; Moreno-Zamora, A; Oton, E; Ruiz, P | 1 |
| Johnson, PJ; Yeo, W | 1 |
| Lai, V; Mirza, D; Mutimer, D; Zhang, WX | 1 |
| Ambrozaitis, A; Im, SJ; Kharchenko, N; Kim, BM; Kim, CM; Kim, CY; Kim, WB; Kim, YM; Lee, CG; Lee, SH; Park, SH; Son, JM; Song, MK; Sung, YC; Wang, JS; Yang, SH; Yoon, SK; Yun, YD | 1 |
| Colak, T; Dalgiç, A; Emiroğlu, R; Filik, L; Gür, G; Haberal, M; Karakayali, H; Moray, G; Ozdemir, N; Yilmaz, U | 1 |
| Akan, M; Akarsu, M; Astarcioğlu, H; Astarcioğlu, I; Karademir, S; Ozkardesler, S; Ozzeybek, D; Sayiner, A; Tankurt, E | 1 |
| Hamada, K; Morikawa, T; Muramatsu, A; Okuno, T; Shindo, M | 1 |
| Schiff, ER; Schreibman, IR | 1 |
| Dan, YY; Lim, SG; Wai, CT; Yeoh, KG | 1 |
| Planas, R; Ribera, JM; Sancho, JM; Vives, S | 1 |
| Hatami, S; Karimi, B; Mohammad Alizadeh, AH; Ranjbar, M | 1 |
| Han, YS; Joh, JW; Kim, DJ; Kim, SJ; Kwon, CH; Lee, SK; Park, JB; Park, JW | 1 |
| Chiba, T; Egawa, H; Marusawa, H; Takada, Y; Ueda, M; Uemoto, S; Umeda, M | 1 |
| Cakir, N; Midilli, K; Pamuk, ON; Umit, H | 1 |
| Cho, JY; Joh, JW; Kim, SI; Kwon, CH; Lee, KU; Lee, KW; Lee, SK; Suh, KS; Yi, NJ | 1 |
| Calleja, JL; Peñas, B | 1 |
| Jiao, Z; Jiao, ZY | 1 |
| Cai, CJ; Chen, GH; Jiang, H; Jiang, N; Li, H; Li, X; Lu, MQ; Wang, GS; Xu, C; Yang, Y; Yi, HM; Yi, SH; Zhang, J; Zhang, JF; Zhang, Q; Zhang, YC | 1 |
| Buster, EH; Cianciara, J; de Vries, RA; Flink, HJ; Hansen, BE; Janssen, HL; Kitis, G; Merican, I; Nevens, F; Schalm, SW | 1 |
| Goto, H; Hayashi, K; Hirooka, Y; Honda, T; Ishigami, M; Itoh, A; Katano, Y; Kumada, T; Kuzuya, T; Nakano, I; Toyoda, H | 1 |
| Cho, EH; Cho, JY; Cho, YB; Kwon, CH; Lee, HW; Lee, KU; Suh, KS; Yang, SH; Yi, NJ | 1 |
| Akyildiz, M; Aydin, U; Karasu, Z; Kilic, M; Ozacar, T; Zeytunlu, M | 1 |
| Busuttil, RW; Cameron, AM; Ghobrial, RM; Hiatt, JR; Tong, MJ; Zimmerman, MA | 1 |
| Bao, SP; Guan, ZZ; He, YF; He, YJ; Huang, HQ; Jiang, WQ; Li, YH; Lin, TY; Sun, XF; Wang, FH; Xia, ZJ; Xu, RH; Zhang, L | 1 |
| Shen, ZY; Song, HL; Wang, J; Wang, ZL; Zheng, WP | 1 |
| de Man, RA; Heijtink, RA; Honkoop, P; Schalm, SW | 1 |
| Bain, VG; Fischer, KP; Kneteman, NM; Ma, MM; Tipples, GA; Tyrrell, DL | 1 |
| Ahmed, M; Beranek, P; Brown, D; Burroughs, AK; Dusheiko, G; Elias, E; Grellier, L; Kennedy, F; Kibbler, H; McMaster, P; McPhillips, P; Mutimer, D; Rolles, K | 1 |
| Bartholomew, MM; Brown, NA; Bunzendahl, H; Condreay, LD; Jansen, RW; Jeffers, LJ; Johnson, LC; Reddy, KR; Schiff, ER; Tzakis, AG | 1 |
| Ben-Ari, Z; Mor, E; Shapira, Z; Shmueli, D; Tur-Kaspa, R | 1 |
| Niederau, C | 1 |
| Cattral, MS; Greig, PD; Hemming, AW; Levy, G; Lilly, LB; Philosophe, B; Superina, RA | 1 |
| Al Faraidy, K; Anderson, FH; Davis, JE; Steinbrecher, UP; Vartanian, RK; Yoshida, EM | 1 |
| Goldstein, H; Katopodis, NF; Kim, A; Kollmann, TR; Pettoello-Mantovani, M; Raker, C; Wiltshire, H; Yurasov, S | 1 |
| Bain, VG; Davis, JE; Erb, SR; Fischer, KP; Kneteman, NM; Ma, MM; Tyrrell, DL; Yoshida, EM | 1 |
| Arnold, JC; Golling, M; Herfarth, C; Otto, G; Rudek, B; Theilmann, L | 1 |
| Herrero, JI; Pardo, F; Prieto, J; Quiroga, J; Riezu-Boj, JI; Sangro, B; Sola, I | 1 |
| Chambers, S; Chapman, BA; Clark, FL; Drummond, MW; Patton, WN | 1 |
| Condreay, L; Debernardi-Venon, W; Marzano, A; Rizzetto, M | 1 |
| Nery, JR; Rodriguez, M; Ruiz, P; Schiff, ER; Tzakis, AG; Weppler, D | 1 |
| Addo, M; Altfeld, M; Kupfer, B; Pult, I; Rockstroh, JK; Spengler, U; Will, H | 1 |
| Bartholomeusz, AI; de Man, RA; Locarnini, SA; Niesters, HG; Zondervan, PE | 1 |
| Andreone, P; Belli, L; Bernardi, M; Caraceni, P; Cavallari, A; D'Errico, A; Dal Monte, PR; Ercolani, G; Forti, D; Grazi, GL; Ideo, G; Jovine, E; Mazziotti, A; Milandri, GL | 1 |
| Ben-Ari, Z; Fraser, G; Kazetsker, A; Tur-Kaspa, R; Zemel, R | 1 |
| Ahmed, M; Barmat, S; Boxall, E; Buchan, S; Burroughs, N; Cane, P; Dragon, E; Elias, E; Gutekunst, K; Martin, B; McMaster, P; Mutimer, D; O'Donnell, K; Pillay, D; Rand, D; Shaw, J; Tang, H | 1 |
| Buti, M; Cotrina, M; Cruz de Castro, E; Esteban, R; Guardia, J; Jardí, R; Rodríguez, F | 1 |
| de Man, RA; Niesters, HG; Schalm, SW; Wolters, LM | 1 |
| Esquivel, CO; Garcia, G; Imperial, JC; Keeffe, EB; Monge, H; So, SK | 1 |
| Bock, T; Böker, KH; Bruns, I; Condreay, LD; Gauthier, J; Glowienka, M; Jäckel, E; Manns, MP; Oldhafer, K; Raab, HR; Tillmann, HL; Trautwein, C | 1 |
| Ben-Ari, Z; Mor, E; Pappo, O; Tur-Kaspa, R; Zemel, R | 1 |
| Bessesen, M; Condreay, L; Ives, D; Lawrence, S; Sherman, KE | 1 |
| Farrell, GC | 1 |
| Bárcena, R; del Campo, S; Domínguez-Antonaya, M; López-Sanromán, A; Martínez-Turnes, A; Moreno, N; Urman, J | 1 |
| Briceno, MN; Garcia-Kennedy, R; Gish, RR; Osorio, RW; Poordad, FF; Roberts, JP; Yao, FY | 1 |
| Angus, PW; Bartholomeusz, A; Bowden, S; Chui, AK; Jones, RM; Koorey, D; Littlejohn, M; Locarnini, SA; McCaughan, GW; Sheil, AG; Spencer, J; Verran, D | 1 |
| Rizzetto, M; Saracco, G | 1 |
| Erhardt, A; Häussinger, D; Heintges, T; Petry, W | 1 |
| Al Asghar, H; Cattral, MS; Greig, PD; Hemming, AW; Humar, A; Levy, GA; Lilly, LB; Malkan, G | 1 |
| Cheung, ST; Fan, ST; Lo, CM | 1 |
| Bucy, RP; Gnann, JW; Goepfert, PA; Kilby, JM; Miller, AP; Saag, MS; Sillers, M | 1 |
| Chung, YH; Lee, HC; Lee, YS; Song, BC; Suh, DJ | 1 |
| Adams, O; Häussinger, D; Petry, W | 1 |
| Barlow, GD; France, AJ | 1 |
| Bechstein, WO; Berg, T; Hopf, U; Langrehr, JM; Müller, AR; Naumann, U; Neuhaus, P; Neuhaus, R; Platz, KP; Rayes, N; Seehofer, D; Steinmüller, T | 1 |
| Marzano, A; Rizzetto, M | 1 |
| Bechstein, WO; Berg, T; Müller, AR; Neuhaus, P; Neuhaus, R; Rayes, N; Seehofer, D | 1 |
| Fischer, L; Rogiers, X; Sterneck, M; Zöllner, B | 1 |
| Ho, MC; Hu, RH; Lai, HS; Lai, MY; Lee, PH; Tsai, MK; Yang, PM | 1 |
| Choi, IS; Choi, SH; Heo, JS; Joh, JW; Kim, SJ; Kim, SM; Kim, YI; Koh, KC; Lee, BB; Lee, JH; Lee, SK; Lee, WY; Paik, SW; Park, JH; Peck, KR; Sohn, TS; Song, JH | 1 |
| Beleza, M; Gomes, A; Macedo, G; Maia, JC; Ribeiro, A; Teixeira, A | 1 |
| Henney, JE | 1 |
| Bruno, R; Filice, C; Filice, G; Sacchi, P | 1 |
| Martin, P; Rosen, HR | 1 |
| Han, DJ; Jung, JG; Kim, SB; Kim, SC; Kim, TH; Lee, SK; Park, JS; Park, SK; Yang, WS; Yu, ES | 1 |
| Allegra, CJ; Hamilton, JM; Little, RF; Saif, MW; Wilson, WH | 1 |
| Boeker, KH; Manns, MP; Rosenau, J; Tillmann, HL; Trautwein, C | 1 |
| Heathcote, EJ; Hoofnagle, JH; Lok, AS | 1 |
| Cahlin, C; Friman, S; Olausson, M | 1 |
| Han, SH; Jensen, D; Keeffe, EB; Lok, AS; Luketic, V; Teo, EK; Terrault, N | 1 |
| Anschuetz, G; Baker, A; Brown, N; Everson, G; Fontana, RJ; Hann, HW; Riely, C; Riker-Hopkins, M; Schiff, ER; Wright, T | 1 |
| Werle, B; Zoulim, F | 1 |
| Bahr, MJ; Klempnauer, J; Manns, MP; Rosenau, J; Tillmann, HL; Trautwein, C | 1 |
| Anschuetz, G; Atkins, M; Barrett, CA; Bassendine, M; Burra, P; Caccamo, L; de Man, RA; Iemmolo, RM; Lopes, AR; Naoumov, NV; O'Grady, JG; Portmann, BC; Williams, R | 1 |
| Barbui, AM; Ciancio, A; David, E; Debernardi-Venon, W; Franchello, A; Gentilcore, E; Marzano, A; Negro, F; Piantino, P; Rizzetto, M; Salizzoni, M; Smedile, A | 1 |
| Chen, DS; Chen, PJ; Kao, JH; Lai, MY; Liu, CJ | 1 |
| Boucher, CA; Cohen Stuart, JW; de Jong, D; Kaye, S; Kovacs, C; Righart, M; Schuurman, R; Visser, CJ; Wensing, AM | 1 |
| Bechstein, WO; Berg, T; Müller, AR; Naumann, U; Neuhaus, P; Neuhaus, R; Rayes, N; Seehofer, D; Steinmüller, T; Tullius, SG | 1 |
| Dodson, FS; Rakela, J; Vargas, HE | 1 |
| Andriani, A; Barlattani, A; Bibas, M; Stroffolini, T | 1 |
| Eng, HL; Lee, CM; Liao, CA; Lu, SN; Wang, MC; Wu, HC | 1 |
| Devecioglu, C; Dikici, B; Ece, A; Haspolat, K; Söker, M | 1 |
| Duan, Y; Liang, S; Wang, F; Yuan, G; Zhu, L | 1 |
| McLean, K; Winston, A | 1 |
| Asaka, M; Chiba, K; Hashino, S; Hige, S; Izumiyama, K; Kondo, T; Nozawa, A; Suzuki, S; Yonezumi, M | 1 |
| Changchien, CS; Chen, CH; Hung, CH; Lee, CM; Lu, SN; Wang, JH | 1 |
| Anselmo, DM; Baquerizo, A; Busuttil, RW; Cao, C; Chen, PW; Farmer, DG; Geevarghese, S; Ghobrial, RM; Goldstein, L; Gornbein, JA; Han, SH; Holt, CD; Jung, LC; Kunder, G; Saab, S; Weaver, M; Yersiz, H | 1 |
| Carey, W; Fontana, RJ; Fried, M; Keeffe, EB; Kowdley, KV; Lok, AS; McClure, LA; Reddy, R; Soldevila-Pico, C | 1 |
| Cho, SW; Hahm, KB; Kim, HJ; Kim, JH; Kim, SW; Lee, KM | 1 |
| Araya, VR; Manzarbeitia, C; Munoz, SJ; Ortiz, JA; Reich, DJ; Rothstein, KD | 1 |
| Chesky, A; Demetris, AJ; Dodson, FS; Dvorchik, I; Fung, JJ; Gray, E; Joya-Vazquez, PP; Shakil, O; Vargas, HE | 1 |
| Choi, MS; Joh, JW; Kim, SJ; Koh, KC; Lee, JH; Lee, SK; Paik, SW; Park, SJ | 1 |
| Dimou, E; Hadziyannis, SJ; Laras, A; Papadimitropoulos, V; Papatheodoridis, GV | 1 |
37 review(s) available for lamivudine and Recrudescence
| Article | Year |
|---|---|
Prophylactic managements of hepatitis B viral infection in liver transplantation.
Topics: Antiviral Agents; Drug Therapy, Combination; Hepatitis B; Hepatitis B Vaccines; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Recurrence; Risk Factors; Secondary Prevention; Tissue Donors | 2016 |
[Is it possible to stop nucleos(t)ide analogue based therapy in chronic hepatitis B?].
Topics: Adenine; Antiviral Agents; DNA, Viral; Hepatitis B Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Organophosphonates; Recurrence | 2008 |
Hepatitis B immune globulin and HBV-related liver transplantation.
Topics: Antiviral Agents; DNA, Viral; Hepatitis B; Hepatitis B Antibodies; Hepatitis B virus; Humans; Immunoglobulins; Immunotherapy; Lamivudine; Liver Transplantation; Recurrence; Treatment Outcome; Virology | 2008 |
Efficacy of entecavir treatment for lamivudine-resistant hepatitis B over 3 years: histological improvement or entecavir resistance?
Topics: Adult; Aged; Alanine Transaminase; Antiviral Agents; DNA, Viral; Drug Administration Schedule; Drug Resistance, Multiple, Viral; Female; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Japan; Lamivudine; Liver; Male; Middle Aged; Mutation; Recurrence; Time Factors; Treatment Outcome | 2009 |
Liver grafts from anti-hepatitis B core positive donors: a systematic review.
Topics: Algorithms; Antiviral Agents; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Humans; Lamivudine; Liver Transplantation; Recurrence; Risk Factors; Tissue Donors; Treatment Outcome | 2010 |
Current therapeutic strategies for recurrent hepatitis B virus infection after liver transplantation.
Topics: Adenine; Antiviral Agents; Asia; Guanine; Hepatitis B; Hepatitis B virus; Humans; Interferons; Lamivudine; Liver Transplantation; Organophosphonates; Recurrence; Reverse Transcriptase Inhibitors; Tenofovir | 2010 |
Impact of immunosuppression and chemotherapy on reactivation of viral hepatitis.
Topics: Antiviral Agents; Hepacivirus; Hepatitis A; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis C; Hepatitis Delta Virus; Humans; Immunosuppression Therapy; Lamivudine; Recurrence; Virus Activation | 2010 |
The difficulties of managing severe hepatitis B virus reactivation.
Topics: Antiviral Agents; DNA, Viral; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Recurrence; Virus Activation | 2011 |
Prevention of and treatment for hepatitis B virus infection after liver transplantation in the nucleoside analogues era.
Topics: Adenine; Antiviral Agents; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Transplantation; Nucleosides; Organophosphonates; Postoperative Complications; Recurrence; Time Factors; Transplantation Immunology | 2003 |
Experience with lamivudine therapy for hepatitis B virus infection before and after liver transplantation, and review of the literature.
Topics: Antiviral Agents; DNA, Viral; Female; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Recurrence; Treatment Outcome; Virus Replication | 2003 |
[Hepatitis: associated diseases. Risk groups -- prevention -- treatment].
Topics: Adenine; Adult; Antiviral Agents; Child; DNA, Viral; Female; Hepacivirus; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C; Hepatitis C, Chronic; Humans; Infant; Infant, Newborn; Interferons; Lamivudine; Liver Cirrhosis; Male; Mutation; Organophosphonates; Recurrence; Ribavirin; Risk Factors; RNA, Viral; Time Factors | 2003 |
Nucleoside analogues and other antivirals for treatment of hepatitis B in the peritransplant period.
Topics: Adenine; Antiviral Agents; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Nucleosides; Organophosphonates; Preoperative Care; Recurrence; Virus Replication | 2003 |
Treatment of hepatitis B reinfection after liver transplantation.
Topics: Drug Therapy, Combination; Hepatitis B; Humans; Immunization, Passive; Immunoglobulins; Interferon-alpha; Lamivudine; Liver Transplantation; Recurrence; Reverse Transcriptase Inhibitors | 2003 |
Mechanisms of hepatitis B virus graft reinfection and graft damage after liver transplantation.
Topics: Antiviral Agents; Genome, Viral; Hepatitis B Antibodies; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Transplantation; Recurrence; Treatment Failure | 2004 |
Treatment of hepatitis B with interferon and combination therapy.
Topics: Antiviral Agents; Drug Therapy, Combination; Hepatitis B Core Antigens; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Polyethylene Glycols; Recombinant Proteins; Recurrence | 2004 |
Management of hepatitis B in liver transplant patients.
Topics: Antiviral Agents; Hepatitis B; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Postoperative Complications; Recurrence; Risk Factors | 2005 |
[Management of chronic hepatitis B].
Topics: Adenine; Adolescent; Adult; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Mutation; Organophosphonates; Patient Selection; Polyethylene Glycols; Recombinant Proteins; Recurrence; Time Factors; Virus Replication | 2005 |
Treatment of chronic hepatitis B in HIV co-infected patients.
Topics: Antiretroviral Therapy, Highly Active; Comorbidity; Disease Progression; Hepatitis B, Chronic; HIV Infections; Humans; Lamivudine; Recurrence; Reverse Transcriptase Inhibitors; Risk Factors | 2005 |
Treatment of immunosuppressed chronic hepatitis B patients.
Topics: Hepatitis B, Chronic; Humans; Immunosuppression Therapy; Lamivudine; Recurrence; Reverse Transcriptase Inhibitors; Risk Factors | 2005 |
Advances in prophylaxis and treatment of recurrent hepatitis B after liver transplantation.
Topics: Antibiotic Prophylaxis; Antiviral Agents; Hepatitis B; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Lamivudine; Liver Transplantation; Recurrence | 2005 |
Prevention of hepatitis B recurrence after liver transplantation.
Topics: Antiviral Agents; Hepatitis B; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Transplantation; Recurrence | 2005 |
[Prophylaxis and therapy of hepatitis B after liver transplantation].
Topics: Hepatitis B; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Transplantation; Recurrence | 2005 |
Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy.
Topics: Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antibodies, Neoplasm; Antineoplastic Agents; DNA, Viral; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Recurrence; Risk Factors; Rituximab; Virus Activation | 2006 |
[Liver transplantation for complications of hepatitis B].
Topics: Adenine; Antiviral Agents; Clinical Trials as Topic; Drug Resistance, Viral; Drug Therapy, Combination; Follow-Up Studies; Guanine; Hepatitis B Vaccines; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunoglobulins; Lamivudine; Liver Cirrhosis; Liver Transplantation; Mutation; Organophosphonates; Recurrence; Reverse Transcriptase Inhibitors; Tenofovir; Time Factors; Vaccination; Viral Load; Virus Replication | 2006 |
Prevention and treatment of recurrent Hepatitis B after liver transplantation: the current role of nucleoside and nucleotide analogues.
Topics: Adenine; Antiviral Agents; Drug Therapy, Combination; Guanine; Hepatitis B; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Nucleosides; Nucleotides; Organophosphonates; Recurrence; Tenofovir | 2006 |
[Entecavir: a new hope for the treatment of chronic hepatitis B].
Topics: Alanine Transaminase; Antiviral Agents; Aspartate Aminotransferases; DNA, Viral; Double-Blind Method; Drug Resistance, Viral; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; HIV Infections; Humans; Lamivudine; Liver Cirrhosis; Liver Transplantation; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Recurrence; Treatment Outcome; Viremia | 2007 |
[Chronic viral hepatitis caused by B and C virus: diagnostic and therapeutic trends].
Topics: Antiviral Agents; DNA, Viral; Genotype; Hepacivirus; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferons; Lamivudine; Polymerase Chain Reaction; Recurrence; Ribavirin; RNA, Viral | 1999 |
[New developments in therapy of chronic hepatitis B. When are nucleoside analogs indicated?].
Topics: Adenine; Antiviral Agents; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Liver Transplantation; Long-Term Care; Organophosphonates; Recurrence; Reverse Transcriptase Inhibitors | 2000 |
Recurrence of the acute HIV syndrome after interruption of antiretroviral therapy in a patient with chronic HIV infection: A case report.
Topics: Acute Disease; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Chronic Disease; Disease Progression; Drug Therapy, Combination; Fever; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Male; Recurrence; Reverse Transcriptase Inhibitors; RNA, Viral; Syndrome; Viral Load; Zidovudine | 2000 |
Posttransplantation prevention and treatment of recurrent hepatitis B.
Topics: Antiviral Agents; Drug Resistance; Hepatitis B; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Transplantation; Recurrence | 2000 |
Hepatitis B and C in the liver transplant recipient.
Topics: Graft Enhancement, Immunologic; Hepatitis B; Hepatitis C; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Recurrence; Reverse Transcriptase Inhibitors; Risk Factors | 2000 |
Reactivation of chronic hepatitis B infection following intensive chemotherapy and successful treatment with lamivudine: a case report and review of the literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Hepatitis B, Chronic; Humans; Immunocompromised Host; Lamivudine; Liver; Lymphoma, Non-Hodgkin; Male; Middle Aged; Recurrence; Reverse Transcriptase Inhibitors; Treatment Outcome | 2001 |
Management of hepatitis B: 2000--summary of a workshop.
Topics: Animals; Disease Models, Animal; DNA, Viral; Drug Resistance, Microbial; Drug Therapy, Combination; Hepatitis B; Hepatitis B Vaccines; Humans; Interferon-alpha; Lamivudine; Liver Transplantation; Recurrence | 2001 |
[Current knowledge on chronic hepatitis B therapy].
Topics: Adenine; Antiviral Agents; Drug Resistance, Microbial; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Organophosphonates; Recurrence; Reverse Transcriptase Inhibitors | 2001 |
Liver transplantation and hepatitis B virus infection: the situation seems to be under control, but the virus is still there.
Topics: Antiviral Agents; DNA, Viral; Hepatitis B; Hepatitis B Antibodies; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Recurrence; Risk Factors | 2001 |
A concise update on the status of liver transplantation for hepatitis B virus: the challenges in 2002.
Topics: DNA, Viral; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Transplantation; Recurrence | 2002 |
Interferon-alpha treatment as a possible cause of relapse in a child with precursor B acute lymphoblastic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Fatal Outcome; Hepatitis B, Chronic; Humans; Immunologic Factors; Interferon-alpha; Lamivudine; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Remission Induction; Sepsis | 2001 |
31 trial(s) available for lamivudine and Recrudescence
| Article | Year |
|---|---|
Comparison of prednisolone and lamivudine combined therapy with prednisolone monotherapy on carriers of hepatitis B virus with IgA nephropathy: a prospective cohort study.
Topics: Adult; Alanine Transaminase; Anti-Inflammatory Agents; Antiviral Agents; Carrier State; Drug Therapy, Combination; Female; Follow-Up Studies; Glomerulonephritis, IGA; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Prednisolone; Prospective Studies; Proteinuria; Recurrence; Treatment Outcome; Virus Activation | 2014 |
Lamivudine switch therapy in chronic hepatitis B patients achieving undetectable hepatitis B virus DNA after 3 years of entecavir therapy: A prospective, open-label, multicenter study.
Topics: Adult; Case-Control Studies; Demography; DNA, Viral; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Prospective Studies; Recurrence; Risk Factors | 2016 |
Sustained HBeAg and HBsAg loss after long-term follow-up of HBeAg-positive patients treated with peginterferon alpha-2b.
Topics: Adult; Alanine Transaminase; Antiviral Agents; Canada; China; DNA, Viral; Drug Therapy, Combination; Europe; Female; Genotype; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Male; Middle Aged; Mutation; Polyethylene Glycols; Promoter Regions, Genetic; Proportional Hazards Models; Recombinant Proteins; Recurrence; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Viral Core Proteins | 2008 |
Relapse of hepatitis B in HBeAg-negative chronic hepatitis B patients who discontinued successful entecavir treatment: the case for continuous antiviral therapy.
Topics: Alanine Transaminase; Antiviral Agents; DNA, Viral; Double-Blind Method; Drug Resistance, Viral; Guanine; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Recurrence; Viral Load | 2009 |
Efficacy of entecavir treatment for lamivudine-resistant hepatitis B over 3 years: histological improvement or entecavir resistance?
Topics: Adult; Aged; Alanine Transaminase; Antiviral Agents; DNA, Viral; Drug Administration Schedule; Drug Resistance, Multiple, Viral; Female; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Japan; Lamivudine; Liver; Male; Middle Aged; Mutation; Recurrence; Time Factors; Treatment Outcome | 2009 |
Nevirapine/zidovudine/lamivudine has superior immunological and virological responses not reflected in clinical outcomes in a 48-week randomized comparison with abacavir/zidovudine/lamivudine in HIV-infected Ugandan adults with low CD4 cell counts.
Topics: Adult; Body Weight; CD4 Lymphocyte Count; Dideoxynucleosides; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Medication Adherence; Middle Aged; Nevirapine; Recurrence; Reverse Transcriptase Inhibitors; RNA, Viral; Treatment Outcome; Uganda; Viral Load; Zidovudine | 2010 |
Clinical efficacy of a 24-months course of lamivudine therapy in patients with HBeAg negative chronic hepatitis B: a long-term prospective study.
Topics: Adult; Aged; Antiviral Agents; Female; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Recurrence; Time Factors; Treatment Outcome | 2010 |
Prediction of sustained response to peginterferon alfa-2b for hepatitis B e antigen-positive chronic hepatitis B using on-treatment hepatitis B surface antigen decline.
Topics: Adult; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Male; Middle Aged; Polyethylene Glycols; Predictive Value of Tests; Recombinant Proteins; Recurrence; Treatment Outcome | 2010 |
Lamivudine plus adefovir is a good option for chronic hepatitis B patients with viral relapse after cessation of lamivudine treatment.
Topics: Adenine; Adult; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis B, Chronic; Humans; Lamivudine; Male; Organophosphonates; Prospective Studies; Recurrence; Salvage Therapy; Treatment Outcome; Withholding Treatment | 2011 |
Preemptive lamivudine therapy based on HBV DNA level in HBsAg-positive kidney allograft recipients.
Topics: Adult; DNA, Viral; Drug Resistance, Viral; Female; Graft Survival; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Kidney Transplantation; Lamivudine; Male; Middle Aged; Postoperative Complications; Prospective Studies; Recurrence; Reverse Transcriptase Inhibitors; Transplantation, Homologous; Treatment Outcome; Virus Replication | 2002 |
Durability of lamivudine-induced HBeAg seroconversion for chronic hepatitis B patients with acute exacerbation.
Topics: Acute Disease; Adolescent; Adult; Alanine Transaminase; Female; Follow-Up Studies; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Predictive Value of Tests; Recurrence; Reverse Transcriptase Inhibitors | 2002 |
Interferon for treatment of breakthrough infection with hepatitis B virus mutants developing during long-term lamivudine therapy.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Drug Resistance, Viral; Drug Therapy, Combination; Female; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferons; Lamivudine; Male; Middle Aged; Mutation; Recurrence; Reverse Transcriptase Inhibitors; Time Factors; Treatment Outcome | 2002 |
Lamivudine therapy in renal allograft recipients with hepatitis B virus infection.
Topics: Adult; Antiviral Agents; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunosuppressive Agents; Kidney Transplantation; Lamivudine; Male; Postoperative Complications; Recurrence; Retrospective Studies; Reverse Transcriptase Inhibitors; Virus Activation | 2003 |
Dynamic alteration of HBV markers on active HBV replicative recipients after liver transplantation: a preliminary report.
Topics: Adult; Aged; Biomarkers; DNA, Viral; Female; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Prospective Studies; Recurrence; Reverse Transcriptase Inhibitors; Virus Replication | 2003 |
Re-treatment of patients with anti-HBe-positive chronic hepatitis B who relapsed after an initial course of lamivudine.
Topics: Adult; Antiviral Agents; DNA, Viral; Drug Evaluation; Drug Resistance, Viral; Female; Follow-Up Studies; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Male; Recurrence; Retreatment; Reverse Transcriptase Inhibitors | 2003 |
[The influence of lamivudine therapy on the course of chronic hepatitis B in renal allograft recipients].
Topics: Adult; Alanine Transaminase; Female; Hepatitis B, Chronic; Humans; Kidney Transplantation; Lamivudine; Male; Middle Aged; Recurrence; Reverse Transcriptase Inhibitors | 2003 |
End-of-treatment virologic response does not predict relapse after lamivudine treatment for chronic hepatitis B.
Topics: Adult; DNA, Viral; Female; Follow-Up Studies; Genotype; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Recurrence; Reverse Transcriptase Inhibitors; Treatment Outcome; Viral Load | 2004 |
Long-term follow-up of peginterferon and lamivudine combination treatment in HBeAg-positive chronic hepatitis B.
Topics: Adult; Antiviral Agents; DNA, Viral; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Gene Dosage; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Male; Polyethylene Glycols; Predictive Value of Tests; Prognosis; Recombinant Proteins; Recurrence; Reverse Transcriptase Inhibitors; Viral Load | 2005 |
Flares in chronic hepatitis B patients induced by the host or the virus? Relation to treatment response during Peg-interferon {alpha}-2b therapy.
Topics: Adult; Alanine Transaminase; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Female; Genotype; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Recurrence; Treatment Outcome | 2005 |
Efficacy of lamivudine re-treatment for relapsed patients after an initial lamivudine therapy in HBeAg-positive chronic hepatitis B.
Topics: Adult; Alanine Transaminase; Antiviral Agents; Female; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Male; Recurrence; Retreatment | 2005 |
High rates of early HBeAg seroconversion and relapse in Indian patients of chronic hepatitis B treated with Lamivudine: results of an open labeled trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alanine Transaminase; Child; Child, Preschool; DNA, Viral; Female; Follow-Up Studies; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Incidence; India; Lamivudine; Male; Middle Aged; Recurrence; Reverse Transcriptase Inhibitors | 2005 |
Interferon/long-term lamivudine combination therapy in anti-HBe positive chronic hepatitis B patients.
Topics: Adult; Aged; Antiviral Agents; Drug Administration Schedule; Drug Resistance, Viral; Drug Therapy, Combination; Female; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferons; Lamivudine; Male; Middle Aged; Mutation; Recurrence; Reverse Transcriptase Inhibitors; Time Factors | 2005 |
Pegylated interferon and ribavirin for the recurrence of chronic hepatitis C genotype 1 in transplant patients.
Topics: Adult; Antiviral Agents; Biopsy; Female; Hepatitis B; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Liver Transplantation; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Recurrence; Ribavirin; Treatment Outcome | 2005 |
Relapse after treatment with peginterferon alpha-2b alone or in combination with lamivudine in HBeAg positive chronic hepatitis B.
Topics: Antiviral Agents; Drug Therapy, Combination; Follow-Up Studies; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Polyethylene Glycols; Recombinant Proteins; Recurrence; Risk Factors | 2007 |
Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis.
Topics: DNA, Viral; Fibrosis; Hepatitis B; Hepatitis B Surface Antigens; Humans; Lamivudine; Liver Failure; Liver Transplantation; Recurrence | 1996 |
High pre-treatment serum hepatitis B virus titre predicts failure of lamivudine prophylaxis and graft re-infection after liver transplantation.
Topics: Antiviral Agents; DNA, Viral; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Transplantation; Polymerase Chain Reaction; Prognosis; Recurrence; Treatment Failure; Virus Replication | 1999 |
[One year treatment with lamivudine in different hepatitis B virus related hepatic diseases].
Topics: Adult; Antiviral Agents; DNA, Viral; Female; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Transplantation; Male; Middle Aged; Recurrence; Reverse Transcriptase Inhibitors | 1999 |
Results on preemptive or prophylactic treatment of lamivudine in HBsAg (+) renal allograft recipients: comparison with salvage treatment after hepatic dysfunction with HBV recurrence.
Topics: DNA, Viral; Female; Graft Rejection; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Kidney Transplantation; Lamivudine; Liver Diseases; Male; Recurrence; Reverse Transcriptase Inhibitors; Salvage Therapy | 2001 |
Randomized trial of lamivudine versus hepatitis B immunoglobulin for long-term prophylaxis of hepatitis B recurrence after liver transplantation.
Topics: Adult; Antiviral Agents; DNA, Viral; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver; Liver Transplantation; Male; Middle Aged; Mutation; Recurrence | 2001 |
[Prevention and treatment of HBV reinfection following liver transplantation].
Topics: 2-Aminopurine; Adult; Antiviral Agents; Biopsy; DNA, Viral; Drug Combinations; Famciclovir; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Postoperative Care; Preoperative Care; Recurrence | 2002 |
Is lamivudine with 1-week HBlg as effective as long-term high-dose HBlg in HBV prophylaxis after liver transplantation?
Topics: Adult; Disease-Free Survival; Drug Administration Schedule; Female; Follow-Up Studies; Hepatitis B; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Prospective Studies; Recurrence; Retrospective Studies; Reverse Transcriptase Inhibitors; Survival Rate; Time Factors | 2002 |
209 other study(ies) available for lamivudine and Recrudescence
| Article | Year |
|---|---|
HBV, antivirals, and immunoglobulins after liver transplantation: all that glitters is not gold.
Topics: Antiviral Agents; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Recurrence; Secondary Prevention; Treatment Outcome | 2023 |
HBV prophylaxis after liver transplantation: close to the full success but at the price of long-term prophylaxis adapted to the risk of HBV recurrence.
Topics: Antiviral Agents; Hepatitis B virus; Humans; Lamivudine; Liver Transplantation; Recurrence; Secondary Prevention; Treatment Outcome | 2023 |
Proliferation of primary human hepatocytes and prevention of hepatitis B virus reinfection efficiently deplete nuclear cccDNA in vivo.
Topics: Animals; Cell Division; Cell Proliferation; Chimera; Disease Models, Animal; DNA, Circular; DNA, Viral; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Humans; Keratin-18; Lamivudine; Lipopeptides; Mice; Primary Cell Culture; Recurrence; Reverse Transcriptase Inhibitors; Viral Load; Virus Integration; Virus Replication | 2018 |
Is hepatitis B immune globulin still needed after liver transplantation for chronic hepatitis B?
Topics: Antiviral Agents; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Recurrence | 2017 |
Oral Nucleos(t)ide Analogs Alone After Liver Transplantation in Chronic Hepatitis B With Preexisting rt204 Mutation.
Topics: Administration, Oral; Adult; Aged; Antiviral Agents; DNA, Viral; Drug Administration Schedule; Drug Resistance, Viral; End Stage Liver Disease; Female; Genotype; Graft Survival; Hepatitis B virus; Hepatitis B, Chronic; Humans; Kaplan-Meier Estimate; Lamivudine; Liver Transplantation; Male; Middle Aged; Mutation; Nucleosides; Nucleotides; Recurrence; Risk Factors; Time Factors; Treatment Outcome; Viral Load; Virus Activation | 2017 |
Sustained antiviral effects and clearance of hepatitis surface antigen after combination therapy with entecavir and pegylated interferon in chronic hepatitis B.
Topics: Adult; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Female; Follow-Up Studies; Genotype; Guanine; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Recurrence; Sustained Virologic Response | 2018 |
48-Week Outcome after Cessation of Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Patient and the Associated Factors with Relapse.
Topics: Adenine; Adult; Antiviral Agents; Female; Follow-Up Studies; Guanine; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Nucleosides; Organophosphonates; Outpatients; Prognosis; Prospective Studies; Recurrence; Risk Factors; RNA, Viral; Telbivudine; Time Factors; Treatment Outcome; Withholding Treatment | 2018 |
Snapshot on drug-resistance rate and profiles in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice.
Topics: Adenine; Adult; Antiviral Agents; Cohort Studies; DNA, Viral; Drug Resistance, Viral; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Mutation; Organophosphonates; Recurrence; Telbivudine; Thymidine; Treatment Outcome | 2013 |
Comparison of re-treatment outcomes of lamivudine plus adefovir or entecavir in chronic hepatitis B patients with viral relapse after cessation of adefovir.
Topics: Adenine; Adult; Antiviral Agents; Case-Control Studies; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Female; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Function Tests; Male; Organophosphonates; Prospective Studies; Recurrence; Treatment Outcome | 2013 |
Serum hepatitis B surface antigen kinetics in severe reactivation of hepatitis B e antigen negative chronic hepatitis B patients receiving nucleoside/nucleotide analogues.
Topics: Adult; Aged; Alanine Transaminase; Antiviral Agents; DNA, Viral; Female; Guanine; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Nucleic Acid Synthesis Inhibitors; Recurrence; Reverse Transcriptase Inhibitors; Telbivudine; Thymidine; Viral Load; Young Adult | 2013 |
Living related liver transplantation for hepatitis B-related liver disease without hepatitis B immune globulin prophylaxis.
Topics: Adenine; Adolescent; Adult; Aged; Antiviral Agents; DNA, Viral; Drug Resistance; Drug Therapy, Combination; Female; Follow-Up Studies; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins; Immunosuppression Therapy; Immunosuppressive Agents; Lamivudine; Liver Transplantation; Living Donors; Male; Middle Aged; Organophosphonates; Prospective Studies; Recurrence; Tenofovir; Treatment Outcome | 2013 |
The role of hepatitis B surface antigen quantification in predicting HBsAg loss and HBV relapse after discontinuation of lamivudine treatment.
Topics: Adult; Aged; Antiviral Agents; Biomarkers; Female; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Incidence; Lamivudine; Male; Middle Aged; Predictive Value of Tests; Recurrence; Regression Analysis; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome; Withholding Treatment | 2014 |
Treatment cessation in noncirrhotic, e-antigen negative chronic hepatitis B is safe and effective following prolonged anti-viral suppression with nucleosides/nucleotides.
Topics: Adenine; Adult; Antiviral Agents; Female; Guanine; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Nucleosides; Nucleotides; Organophosphonates; Recurrence; Tenofovir; Withholding Treatment; Young Adult | 2014 |
Clinicopathological features of hepatitis B virus recurrence after liver transplantation: eleven-year experience.
Topics: Adult; Antiviral Agents; Female; Hepatitis B; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Recurrence | 2014 |
Off-treatment virologic relapse and outcomes of re-treatment in chronic hepatitis B patients who achieved complete viral suppression with oral nucleos(t)ide analogs.
Topics: Adult; Aged; Antiviral Agents; Arabinofuranosyluracil; Drug Resistance, Viral; Female; Genotype; Guanine; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Multivariate Analysis; Recurrence; Retrospective Studies; Treatment Outcome | 2014 |
Telbivudine prophylaxis for hepatitis B virus recurrence after liver transplantation improves renal function.
Topics: Adult; Antiviral Agents; Creatinine; Female; Hepatitis B, Chronic; Humans; Lamivudine; Liver Transplantation; Male; Middle Aged; Recurrence; Telbivudine; Thymidine | 2014 |
[Viral relapse and genetic resistance after a nearly 8-year cessation of lamivudine therapy in a patient with chronic hepatitis B: a case report].
Topics: Adult; Drug Resistance, Viral; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Recurrence | 2014 |
[Clinical pathology of recurrent hepatitis B after liver transplantation].
Topics: Adenine; Antiviral Agents; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Transplantation; Organophosphonates; Recurrence | 2014 |
Combining age and HBsAg level predicts post-treatment durability of nucleos(t)ide analogue-induced HBeAg seroconversion.
Topics: Adult; Aging; Antiviral Agents; Consolidation Chemotherapy; Female; Follow-Up Studies; Forecasting; Hepatitis B; Hepatitis B e Antigens; Humans; Lamivudine; Male; Middle Aged; Molecular Sequence Data; Nucleotides; Recurrence; Retrospective Studies; Risk; Seroconversion; Time Factors; Young Adult | 2015 |
Low-dose short-term hepatitis B immunoglobulin with high genetic barrier antivirals: the ideal post-transplant hepatitis B virus prophylaxis?
Topics: Adenine; Adult; Antiviral Agents; Carcinoma, Hepatocellular; Cohort Studies; Drug Resistance, Viral; Drug Therapy, Combination; Female; Follow-Up Studies; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Organophosphonates; Prospective Studies; Recurrence; Tenofovir | 2015 |
Telbivudine in liver transplant recipients: Renal protection does not overcome the risk of polyneuropathy and myopathy.
Topics: Aged; Antiviral Agents; Diabetes Mellitus; Drug Substitution; End Stage Liver Disease; Female; Glomerular Filtration Rate; Hepatitis B; Humans; Incidence; Kaplan-Meier Estimate; Kidney; Lamivudine; Liver Transplantation; Male; Middle Aged; Muscular Diseases; Polyneuropathies; Proportional Hazards Models; Prospective Studies; Recovery of Function; Recurrence; Renal Insufficiency, Chronic; Risk Factors; Telbivudine; Thymidine; Time Factors; Treatment Outcome; Turkey | 2015 |
Efficacy and safety of lamivudine or tenofovir plus intramuscular hepatitis B immunoglobulin in prevention of hepatitis B virus reinfection after liver transplant.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Child; Drug Administration Schedule; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B virus; Humans; Immunoglobulins; Injections, Intramuscular; Lamivudine; Liver Failure; Liver Transplantation; Male; Middle Aged; Prospective Studies; Recurrence; Tenofovir; Time Factors; Treatment Outcome; Virus Activation; Young Adult | 2015 |
Nucleoside-Nucleotide Analog Combination Therapy Is Effective in Preventing Recurrent Hepatitis B After Liver Transplantation.
Topics: Adenine; Adult; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Female; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Organophosphonates; Prospective Studies; Recurrence; Tenofovir | 2015 |
Ten-year follow-up of hepatitis B relapse after cessation of lamivudine or telbivudine treatment in chronic hepatitis B patients.
Topics: Adolescent; Adult; Antiviral Agents; DNA, Viral; Feasibility Studies; Female; Follow-Up Studies; Hepacivirus; Hepatitis B Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Recurrence; Retrospective Studies; Telbivudine; Thymidine; Young Adult | 2015 |
Adefovir- or Lamivudine-Induced Renal Tubular Dysfunction after Liver Transplantation.
Topics: Adenine; Female; Hepatitis B; Humans; Incidence; Kidney Diseases; Lamivudine; Liver Transplantation; Male; Middle Aged; Organophosphonates; Postoperative Complications; Recurrence; Republic of Korea; Retrospective Studies; Reverse Transcriptase Inhibitors; Risk Factors | 2015 |
Long-term lamivudine for chronic hepatitis B and cirrhosis: A real-life cohort study.
Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; China; Drug Administration Schedule; Drug Resistance, Viral; Hepatitis B, Chronic; Humans; Incidence; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Propensity Score; Prospective Studies; Recurrence; Remission Induction; Retrospective Studies; Risk Factors; Survival Analysis; Time Factors; Treatment Outcome; Viral Load; Young Adult | 2015 |
Clinical outcomes and predictors for relapse after cessation of oral antiviral treatment in chronic hepatitis B patients.
Topics: Administration, Oral; Adult; Age Factors; Aged; Antiviral Agents; DNA, Viral; Drug Administration Schedule; Female; Guanine; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Prognosis; Prospective Studies; Recurrence; Risk Factors; Treatment Outcome; Withholding Treatment; Young Adult | 2016 |
Off-treatment durability of antiviral response to nucleoside analogues in patients with chronic hepatitis B.
Topics: Adult; Alanine Transaminase; Antiviral Agents; Carcinoma, Hepatocellular; Cohort Studies; Disease Progression; DNA, Viral; Female; Follow-Up Studies; Guanine; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Liver Neoplasms; Male; Middle Aged; Polymerase Chain Reaction; Recurrence; Remission Induction; Retrospective Studies; Reverse Transcriptase Inhibitors; Viral Load | 2016 |
Durability of the virological response after lamivudine discontinuation in lamivudine-resistant patients with a complete virological response after lamivudine and adefovir combination therapy.
Topics: Adenine; Adult; Aged; Anti-HIV Agents; DNA, Viral; Drug Therapy, Combination; Female; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Recurrence; Sustained Virologic Response; Time Factors; Withholding Treatment | 2017 |
The long-term efficacy of combining nucleos(t)ide analog and low-dose hepatitis B immunoglobulin on post-transplant hepatitis B virus recurrence.
Topics: Adenine; Administration, Oral; Adult; Aged; Antiviral Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Guanine; Hepatitis B, Chronic; Humans; Immunoglobulins; Immunologic Factors; Kaplan-Meier Estimate; Lamivudine; Liver Transplantation; Male; Middle Aged; Organophosphonates; Postoperative Complications; Proportional Hazards Models; Recurrence; Retrospective Studies; Tenofovir; Treatment Outcome | 2016 |
Delayed, Uncommon Recurrence of Hepatocellular Carcinoma After Liver Transplantation: A Case Report.
Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; Hepatitis B; Hepatitis B virus; Humans; Immunosuppressive Agents; Lamivudine; Liver Neoplasms; Liver Transplantation; Male; Neoplasm Recurrence, Local; Recurrence; Tacrolimus; Tissue Donors; Treatment Outcome | 2016 |
Antiviral response is not sustained after cessation of lamivudine treatment in chronic hepatitis B patients: A 10-year follow-up study.
Topics: Adult; Antiviral Agents; Female; Follow-Up Studies; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Recurrence; Retrospective Studies; Viral Load; Withholding Treatment; Young Adult | 2017 |
Liver enzyme elevation after lamivudine withdrawal in HIV-hepatitis B virus co-infected patients: the Swiss HIV Cohort Study.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Epidemiologic Methods; Female; Hepatitis B; Hepatitis B e Antigens; HIV-1; Humans; Lamivudine; Liver Diseases; Male; Middle Aged; Recurrence; Switzerland; Viral Load | 2009 |
Hepatitis B virus reactivation after a resolutive acute hepatitis leading to a diagnosis of T cell lymphoma.
Topics: Aged; Antiviral Agents; DNA, Viral; Fatal Outcome; Female; Hepatitis B; Hepatitis B e Antigens; Humans; Lamivudine; Lymphoma, T-Cell; Neoplasm Recurrence, Local; Recurrence; Remission, Spontaneous | 2009 |
[Post-transplant prophylaxis of the recurrence of lamivudine-resistant YMDD mutant hepatitis B virus in liver recipients].
Topics: Adult; Aged; Amino Acid Motifs; Antiviral Agents; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Mutation; Recurrence | 2008 |
Durability of antiviral response in HBeAg-positive chronic hepatitis B patients who maintained virologic response for one year after lamivudine discontinuation.
Topics: Adult; Antiviral Agents; DNA, Viral; Female; Follow-Up Studies; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunoradiometric Assay; Lamivudine; Male; Middle Aged; Multivariate Analysis; Recurrence; Remission Induction; Retrospective Studies; Reverse Transcriptase Inhibitors; Risk Factors; Viral Load; Virus Replication | 2009 |
[Lamivudine treatment of a HBs antigen positive man with reactive arthritis].
Topics: Antiviral Agents; Arthritis, Reactive; DNA, Viral; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Recurrence; Reverse Transcriptase Inhibitors; Treatment Outcome | 2008 |
What is the optimal regimen for preventing hepatitis B recurrence after liver transplantation?
Topics: Antiviral Agents; Drug Therapy, Combination; Hepatitis B; Hepatitis B Antibodies; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Recurrence; Treatment Outcome | 2009 |
Costs and efficacy of "on demand" low-dose immunoprophylaxis in HBV transplanted patients: experience in the Romanian program of liver transplantation.
Topics: Adult; Comorbidity; Cost-Benefit Analysis; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis D; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Immunotherapy; Lamivudine; Liver Failure; Liver Transplantation; Male; Middle Aged; Program Evaluation; Recurrence; Retrospective Studies; Reverse Transcriptase Inhibitors; Romania; Survival Analysis; Treatment Outcome | 2008 |
[Virologic response to adefovir dipivoxil monotherapy is not durable in HBeAg-positive, lamivudine-resistant chronic hepatitis B patients].
Topics: Adenine; Adult; Aged; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Female; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Recurrence; Retrospective Studies; Risk Factors | 2009 |
Effective treatment for de novo hepatitis B with nucleotide analogue in patients with hematological malignancies.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cervix Uteri; Cyclophosphamide; Doxorubicin; Etoposide; Female; Guanine; Hematopoietic Stem Cell Transplantation; Hepatitis B; Humans; Lamivudine; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisone; Recurrence; Remission Induction; Stomach; Transplantation, Autologous; Vincristine | 2009 |
[Raised tattoos in a human-immunodeficiency-virus-infected patient].
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiprotozoal Agents; Antiretroviral Therapy, Highly Active; CD4-Positive T-Lymphocytes; Hepatitis C, Chronic; Histiocytes; Humans; Lamivudine; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Lopinavir; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Patient Compliance; Pentamidine; Pyrimidinones; Recurrence; Ritonavir; Tattooing; Zidovudine | 2009 |
Withdrawal of lamivudine in HBeAg-positive chronic hepatitis B patients after achieving effective maintained virological suppression.
Topics: Adult; Aged; Antiviral Agents; DNA, Viral; Female; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Longitudinal Studies; Male; Middle Aged; Recurrence; Treatment Outcome; Withholding Treatment; Young Adult | 2009 |
[Prophylaxsis against recurrance of hepatitis B virus after liver transplantation].
Topics: Adolescent; Adult; Aged; Antibiotic Prophylaxis; Antiviral Agents; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Transplantation; Male; Middle Aged; Recurrence; Young Adult | 2008 |
Stringent cessation criterion results in better durability of lamivudine treatment: a prospective clinical study in hepatitis B e antigen-positive chronic hepatitis B patients.
Topics: Adolescent; Adult; Antiviral Agents; Asian People; DNA, Viral; Female; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Longitudinal Studies; Male; Prospective Studies; Recurrence; Treatment Outcome; Withholding Treatment; Young Adult | 2010 |
Extended lamivudine consolidation therapy in hepatitis B e antigen-positive chronic hepatitis B patients improves sustained hepatitis B e antigen seroconversion.
Topics: Adult; Female; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Recurrence; Retrospective Studies; Reverse Transcriptase Inhibitors; Taiwan; Time Factors; Treatment Outcome | 2010 |
High viremia, prolonged Lamivudine therapy and recurrent hepatocellular carcinoma predict posttransplant hepatitis B recurrence.
Topics: Adult; DNA, Viral; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B virus; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Mutation; Predictive Value of Tests; Recurrence; Retrospective Studies; Reverse Transcriptase Inhibitors | 2010 |
Defining virologic relapse in chronic hepatitis B.
Topics: Adenine; Adult; Antiviral Agents; DNA, Viral; Female; Follow-Up Studies; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Recurrence; Retrospective Studies; Treatment Outcome; Viral Load | 2011 |
To stop or not to stop: the quest for long-term viral suppression.
Topics: Alanine Transaminase; Antiviral Agents; Biomarkers; DNA, Viral; Drug Administration Schedule; Drug Monitoring; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Predictive Value of Tests; Recurrence; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Viral Load | 2011 |
Poor durability of lamivudine effectiveness despite stringent cessation criteria: a prospective clinical study in hepatitis B e antigen-negative chronic hepatitis B patients.
Topics: Adult; Age Factors; Alanine Transaminase; Antiviral Agents; Biomarkers; China; DNA, Viral; Drug Administration Schedule; Drug Monitoring; Female; Follow-Up Studies; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Kaplan-Meier Estimate; Lamivudine; Male; Middle Aged; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Recurrence; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Viral Load; Young Adult | 2011 |
A patient with rheumatoid arthritis treated with tocilizumab together with lamivudine prophylaxis after remission of infliximab-reactivated hepatitis B.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Female; Hepatitis B; Humans; Infliximab; Lamivudine; Middle Aged; Recurrence; Reverse Transcriptase Inhibitors; Treatment Outcome | 2011 |
Predictors of relapse in chronic hepatitis B after discontinuation of anti-viral therapy.
Topics: Adenine; Adult; Antiviral Agents; Female; Guanine; Hepatitis B Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Proportional Hazards Models; Real-Time Polymerase Chain Reaction; Recurrence; Time Factors | 2011 |
Updated longitudinal data on acute exacerbation of chronic hepatitis B in patients with breast cancer receiving anthracycline-based adjuvant chemotherapy: therapeutic vs. pre-emptive use of lamivudine.
Topics: Acute Disease; Adult; Aged; Alanine Transaminase; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Biomarkers; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Female; Hepatitis B, Chronic; Humans; Lamivudine; Liver; Logistic Models; Longitudinal Studies; Medical Records; Middle Aged; Multivariate Analysis; Recurrence; Retrospective Studies; Risk Factors; Secondary Prevention; Taxoids; Treatment Outcome | 2011 |
Virologic response is not durable after adefovir discontinuation in lamivudine-resistant chronic hepatitis B patients.
Topics: Adenine; Adult; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Female; Follow-Up Studies; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Recurrence; Risk Factors | 2011 |
[Prognosis analysis of hepatitis B virus recurrence after liver transplantation: a single-center study of 38 cases].
Topics: Adenine; Adult; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Transplantation; Male; Middle Aged; Organophosphonates; Prognosis; Recurrence; Retrospective Studies | 2012 |
Clinical course of chronic hepatitis B patients who were off-treated after lamivudine treatment: analysis of 138 consecutive patients.
Topics: Adolescent; Adult; Aged; Alanine Transaminase; Antiviral Agents; DNA, Viral; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Recurrence; Retrospective Studies; Treatment Outcome; Viral Load; Withholding Treatment; Young Adult | 2012 |
Should lamivudine monotherapy be stopped or continued in patients infected with hepatitis B with favorable responses after more than 5 years of treatment?
Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; DNA, Viral; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Neoplasms; Male; Middle Aged; Recurrence; Time Factors; Treatment Outcome; Viral Load | 2013 |
Outcome of various treatments for posttransplant hepatitis B virus recurrence.
Topics: Adenine; Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Biomarkers; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Guanine; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Lamivudine; Liver Transplantation; Male; Middle Aged; Organophosphonates; Recurrence; Retrospective Studies; Treatment Outcome; Young Adult | 2013 |
[HBV cirrhosis].
Topics: Antiviral Agents; Hepatitis B; Humans; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Recurrence | 2002 |
Factors associated with viral breakthrough in lamivudine monoprophylaxis of hepatitis B virus recurrence after liver transplantation.
Topics: Adult; Amino Acid Motifs; Amino Acid Sequence; Antiviral Agents; Base Sequence; DNA, Viral; Drug Resistance, Viral; Female; Genes, Viral; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Mutation; Recurrence | 2002 |
Combination prophylaxis with Hepatitis B immunoglobulin and lamivudine after liver transplantation minimizes HBV recurrence rates unless evolution of pretransplant lamivudine resistance.
Topics: Adult; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Follow-Up Studies; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Recurrence; Reverse Transcriptase Inhibitors; Virus Replication | 2002 |
Fatal hepatitis B reactivation following discontinuation of nucleoside analogues for chronic hepatitis B.
Topics: 2-Aminopurine; Adult; Aged; Alanine Transaminase; Antiviral Agents; Bilirubin; DNA, Viral; Drug Resistance, Viral; Famciclovir; Fatal Outcome; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Mutation; Recurrence; Virus Activation | 2002 |
Liver transplantation in hepatitis B patients with preoperative resistance formation during lamivudine treatment.
Topics: Drug Resistance, Viral; Hepatitis B; Humans; Lamivudine; Liver Transplantation; Recurrence; Reoperation; Treatment Outcome | 2002 |
The use of antiviral monotherapy and combination therapy for patients with hepatitis B virus infection after liver transplantation.
Topics: 2-Aminopurine; Antiviral Agents; Drug Therapy, Combination; Famciclovir; Hepatitis B; Hepatitis B Surface Antigens; Humans; Lamivudine; Liver Function Tests; Liver Transplantation; Recurrence | 2002 |
Prophylaxis of hepatitis B recurrence after liver transplantation with lamivudin and hepatitis B immunoglobulin.
Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Hepatitis B; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins, Intravenous; Immunosuppression Therapy; Lamivudine; Liver Transplantation; Male; Middle Aged; Recurrence; Treatment Outcome | 2002 |
Repeated jaundice due to YMDD mutant in a patient with prolonged lamivudine therapy for chronic hepatitis B under prednisolone treatment for Still's disease.
Topics: Amino Acid Sequence; DNA, Viral; Drug Resistance, Viral; Female; Glucocorticoids; Hepatitis B, Chronic; Hepatitis Viruses; Humans; Jaundice; Lamivudine; Middle Aged; Molecular Sequence Data; Mutation; Polymerase Chain Reaction; Prednisolone; Recurrence; Reverse Transcriptase Inhibitors; Sequence Analysis, DNA; Still's Disease, Adult-Onset; Virus Replication | 2002 |
Treatment of recurrent hepatitis B infection in liver transplant recipients.
Topics: 2-Aminopurine; Adenine; Antiviral Agents; Famciclovir; Hepatitis B; Humans; Interferon-alpha; Lamivudine; Liver Transplantation; Organophosphonates; Recurrence; Reverse Transcriptase Inhibitors | 2002 |
Additional benefit of lamivudine treatment as a preventive therapy for hepatic encephalopathy in patients with decompensated liver cirrhosis associated with hepatitis B.
Topics: Antiviral Agents; Female; Hepatic Encephalopathy; Hepatitis B; Humans; Lamivudine; Liver Cirrhosis; Middle Aged; Recurrence | 2002 |
Prophylactic lamivudine therapy for hepatitis B patients undergoing immunosuppressive therapy.
Topics: Antiviral Agents; Hepatitis B; Hepatitis B virus; Humans; Immunosuppressive Agents; Lamivudine; Recurrence; Virus Activation | 2002 |
Evolving experience of hepatitis B virus prophylaxis in liver transplantation.
Topics: Adult; Chemoprevention; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B virus; Humans; Immunization, Passive; Immunoglobulins; Incidence; Lamivudine; Liver Transplantation; Male; Middle Aged; Recurrence; Retrospective Studies; Reverse Transcriptase Inhibitors | 2002 |
Remission of breakthrough hepatitis in chronic hepatitis B patients on lamivudine.
Topics: Antiviral Agents; Drug Resistance, Viral; Hepatitis B, Chronic; Humans; Interferons; Lamivudine; Recurrence; Remission Induction; Reverse Transcriptase Inhibitors | 2002 |
Seroconversion in patients with acute hepatitis B reinfection after liver transplantation with a combined treatment of lamivudine and hepatitis B immune globulin.
Topics: Acute Disease; Adult; Base Sequence; DNA Primers; DNA, Viral; Follow-Up Studies; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver; Liver Transplantation; Male; Middle Aged; Polymerase Chain Reaction; Recurrence; Retrospective Studies; Time Factors | 2002 |
Successful treatment of fibrosing cholestatic hepatitis using adefovir dipivoxil in a patient with cirrhosis and renal insufficiency.
Topics: Adenine; Adult; Antiviral Agents; Bacterial Infections; Cholestasis; Drug Resistance, Microbial; Fibrosis; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver; Liver Cirrhosis; Male; Organophosphonates; Peritonitis; Recurrence; Renal Insufficiency; Reverse Transcriptase Inhibitors | 2003 |
Tenofovir disoproxil fumarate exhibits strong antiviral effect in a patient with lamivudine-resistant severe hepatitis B reactivation.
Topics: Adenine; Antiviral Agents; Drug Resistance, Microbial; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Recurrence; Reverse Transcriptase Inhibitors; Tenofovir; Virus Activation | 2003 |
Multiple relapses of human cytomegalovirus retinitis during HAART in an AIDS patient with reconstitution of CD4+ T cell count in the absence of HCMV-specific CD4+ T cell response.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antiviral Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cytomegalovirus Retinitis; Didanosine; Follow-Up Studies; Ganciclovir; HIV Protease Inhibitors; Humans; Lamivudine; Lymphocyte Activation; Male; Nevirapine; Recurrence; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine | 2003 |
Combination hepatitis B immune globulin and lamivudine versus hepatitis B immune globulin monotherapy in preventing recurrent hepatitis B virus infection in liver transplant recipients.
Topics: Antiviral Agents; DNA, Viral; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins, Intravenous; Lamivudine; Liver Transplantation; Male; Middle Aged; Recurrence; Retrospective Studies | 2003 |
Comparison between levels of anti-HBS with a fixed administration dose of HBIG and a combination of HBIG and lamivudine for the prophylaxis of hepatitis B after liver transplantation.
Topics: Adult; Aged; Antibodies, Viral; Antiviral Agents; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Middle Aged; Postoperative Complications; Recurrence; Retrospective Studies | 2003 |
[Severe exacerbation of chronic hepatitis B during therapy with corticosteroids and lamivudine therapy and successful short-term combination therapy with interferon-beta and interferon-gamma].
Topics: Anti-Inflammatory Agents; Antiviral Agents; Connective Tissue Diseases; Drug Therapy, Combination; Female; Hepatitis B, Chronic; Humans; Interferon Type I; Interferon-gamma; Lamivudine; Liver Function Tests; Lupus Erythematosus, Systemic; Middle Aged; Prednisolone; Recombinant Proteins; Recurrence; Reverse Transcriptase Inhibitors; Virus Activation | 2003 |
A case of relapsing Guillain-Barré syndrome associated with exacerbation of chronic hepatitis B virus hepatitis.
Topics: Aged; Antigen-Antibody Complex; DNA, Viral; Guillain-Barre Syndrome; Hepatitis B Antibodies; Hepatitis B Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Lamivudine; Liver Function Tests; Male; Prednisolone; Recurrence; Time Factors; Viremia; Virus Replication | 2003 |
Cost-effective and safe ambulatory long-term immunoprophylaxis with intramuscular instead of intravenous hepatitis B immunoglobulin to prevent reinfection after orthotopic liver transplantation.
Topics: Adult; Cost-Benefit Analysis; Drug Administration Schedule; Female; Hepatitis B; Humans; Immunization, Passive; Immunoglobulins; Injections, Intramuscular; Injections, Intravenous; Lamivudine; Liver Transplantation; Male; Middle Aged; Recurrence; Reverse Transcriptase Inhibitors; Time Factors | 2003 |
Analysis of clinical, biochemical and viral factors associated with early relapse after lamivudine treatment for hepatitis B e antigen-negative chronic hepatitis B patients in Taiwan.
Topics: Adult; Aged; Base Sequence; Cohort Studies; DNA, Viral; Female; Follow-Up Studies; Genotype; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Molecular Sequence Data; Multivariate Analysis; Polymerase Chain Reaction; Probability; Prospective Studies; Recurrence; Reverse Transcriptase Inhibitors; Risk Assessment; Serologic Tests; Severity of Illness Index; Statistics, Nonparametric; Taiwan; Treatment Outcome; Viral Core Proteins; Viral Load | 2003 |
[Efficacy of lamivudine in patients with hepatitis B e antigen-negative chronic liver diseases].
Topics: Antiviral Agents; DNA, Viral; Female; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Recurrence | 2003 |
Combined lamivudine and hepatitis B immunoglobulin for the prevention of hepatitis B recurrence after liver transplantation: long-term results.
Topics: Adolescent; Adult; Cohort Studies; Drug Therapy, Combination; Female; Hepatitis B; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Recurrence; Survival Rate | 2003 |
Liver transplantation in patients with fulminant hepatitis B: experience in Canton, China.
Topics: Adult; Hepatic Encephalopathy; Hepatitis B; Humans; Lamivudine; Liver Transplantation; Male; Middle Aged; Recurrence; Survival Rate | 2002 |
Use of adefovir in the treatment of the chronic hepatitis B virus infection with resistance to lamivudine.
Topics: Adenine; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Female; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Transplantation; Male; Middle Aged; Organophosphonates; Patient Selection; Recurrence; Treatment Failure; Viremia | 2003 |
Use of combined treatment of hepatitis B immune globulin and lamivudine as prevention of hepatitis B virus recurrence in liver allograft.
Topics: Adult; Aged; Female; Hepatitis B; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Recurrence; Transplantation, Homologous | 2003 |
Prophylaxis of recurrent hepatitis B virus by vaccination after liver transplant: preliminary results.
Topics: Antiviral Agents; Follow-Up Studies; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Vaccines; Humans; Immunization Schedule; Immunoglobulins; Lamivudine; Liver Transplantation; Recurrence; Time Factors | 2003 |
Long-term additional lamivudine therapy enhances durability of lamivudine-induced HBeAg loss: a prospective study.
Topics: Adult; Aging; DNA, Viral; Drug Administration Schedule; Female; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Mutation; Prognosis; Prospective Studies; Recurrence; Reverse Transcriptase Inhibitors; Risk Factors; Time Factors; Viral Core Proteins | 2003 |
[Efficacy of lamivudine re-treatment and relapse patterns after initial lamivudine treatment for chronic hepatitis B infection].
Topics: Adult; Antiviral Agents; Female; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Male; Recurrence; Retreatment | 2003 |
Virological and biochemical relapse according to YMDD motif mutant type during long-term lamivudine monotherapy.
Topics: Adult; Aged; Amino Acid Motifs; Amino Acid Sequence; Antiviral Agents; Female; Gene Products, pol; Genes, Viral; Genotype; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Mutation; Recurrence; Time Factors | 2003 |
Determinants for sustained HBeAg response to lamivudine therapy.
Topics: Adult; Aging; Drug Administration Schedule; Female; Genotype; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Logistic Models; Male; Recurrence; Reverse Transcriptase Inhibitors; Treatment Outcome | 2003 |
Quantitative polymerase chain reaction assay for serum hepatitis B virus DNA as a predictive factor for post-treatment relapse after lamivudine induced hepatitis B e antigen loss or seroconversion.
Topics: Adult; Antiviral Agents; DNA, Viral; Female; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Mutation; Polymerase Chain Reaction; Predictive Value of Tests; Prospective Studies; Recurrence | 2003 |
Role of lamivudine in the reactivation of hepatitis B virus infection in immunodepressed patients.
Topics: Adult; Female; Hepatitis B; Humans; Immunosuppression Therapy; Lamivudine; Male; Middle Aged; Recurrence; Reverse Transcriptase Inhibitors | 2003 |
Hepatitis B-assocciated adult-onset Still's disease presenting with neutrophilic urticaria.
Topics: Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Diagnosis, Differential; Fever of Unknown Origin; Hepatitis B; Humans; Indomethacin; Lamivudine; Male; Prednisolone; Recurrence; Reverse Transcriptase Inhibitors; Still's Disease, Adult-Onset; Time Factors; Urticaria | 2003 |
Predicting relapse after cessation of Lamivudine monotherapy for chronic hepatitis B virus infection.
Topics: Adult; DNA, Viral; Female; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Recurrence; Reverse Transcriptase Inhibitors; Viral Load | 2004 |
Low-dose intramuscular hepatitis B immune globulin and lamivudine for long-term prophylaxis of hepatitis B recurrence after liver transplantation.
Topics: Antiviral Agents; Costs and Cost Analysis; Female; Hepatitis B; Hepatitis B virus; Humans; Immunoglobulins, Intravenous; Italy; Lamivudine; Liver Failure; Liver Transplantation; Male; Middle Aged; Recurrence; Retrospective Studies; Treatment Outcome | 2004 |
Low-dose hepatitis B immunoglobulin given "on demand" in combination with lamivudine: a highly cost-effective approach to prevent recurrent hepatitis B virus infection in the long-term follow-up after liver transplantation.
Topics: Antiviral Agents; Cost-Benefit Analysis; Hepatitis B; Hepatitis B Antibodies; Humans; Immunoglobulins, Intravenous; Lamivudine; Liver Transplantation; Male; Middle Aged; Recurrence | 2004 |
Restoration of immunity and reactivation of hepatitis B virus after immunosuppressive therapy in a patient with severe aplastic anaemia.
Topics: Adult; Anemia, Aplastic; Antilymphocyte Serum; Antiviral Agents; Carrier State; Cyclosporine; Hepatitis B, Chronic; Humans; Immunosuppressive Agents; Lamivudine; Male; Recurrence | 2004 |
Fatal liver failure due to reactivation of lamivudine-resistant HBV mutant.
Topics: Drug Resistance, Viral; Fatal Outcome; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Mutation; Recurrence; Reverse Transcriptase Inhibitors | 2004 |
Genotype prevalence, viral load and outcome of hepatitis B virus precore mutant infection in stable patients and in patients after liver transplantation.
Topics: Adult; Codon, Terminator; DNA, Viral; Female; Genotype; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunosuppressive Agents; Lamivudine; Liver Transplantation; Male; Middle Aged; Mutation; Postoperative Period; Recurrence; Reverse Transcriptase Inhibitors; Seroepidemiologic Studies; Viral Load; Virus Replication | 2004 |
Prompt relapse of viremia after lamivudine discontinuation in e-minus chronic hepatitis B patients completely responders during 5 years of therapy.
Topics: Antiviral Agents; DNA, Viral; Female; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Recurrence; Viremia | 2004 |
Delayed hepatitis B virus reactivation after cessation of preemptive lamivudine in lymphoma patients treated with rituximab plus CHOP.
Topics: Adult; Alanine Transaminase; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bilirubin; Cyclophosphamide; DNA-Directed DNA Polymerase; DNA, Viral; Doxorubicin; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Lymphoma, B-Cell; Male; Mutation; Prednisone; Recurrence; Reverse Transcriptase Inhibitors; Rituximab; Sequence Analysis, DNA; Vincristine; Virus Activation | 2004 |
Events occurring at the time of breakthrough hepatitis during lamivudine treatment for chronic hepatitis B.
Topics: Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Long-Term Care; Mutation; Recurrence; Virus Replication | 2004 |
Sustained response after a 2-year course of lamivudine treatment of hepatitis B e antigen-negative chronic hepatitis B.
Topics: Adult; Asian People; Canada; Drug Resistance, Viral; Female; Genotype; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Mutation; Recurrence; Reverse Transcriptase Inhibitors; Treatment Outcome | 2004 |
Long-term follow-up study of Chinese patients with YMDD mutations: significance of hepatitis B virus genotypes and characteristics of biochemical flares.
Topics: Adolescent; Adult; Amino Acid Sequence; Amino Acid Substitution; DNA, Viral; Female; Follow-Up Studies; Genotype; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Mutation, Missense; Recurrence; RNA-Directed DNA Polymerase | 2004 |
Outcomes in liver transplant recipients with hepatitis B virus: resistance and recurrence patterns from a large transplant center over the last decade.
Topics: Adenine; Adult; Aged; Antiviral Agents; Drug Resistance, Viral; Female; Graft Survival; Hepatitis B; Humans; Immunoglobulins; Lamivudine; Liver Failure; Liver Transplantation; Male; Middle Aged; Organophosphonates; Recurrence; Retrospective Studies; Survival Analysis; Treatment Outcome | 2004 |
[Clinical characteristics of and the related factors to the relapse of chronic hepatitis B after lamivudine withdrawal].
Topics: Adolescent; Adult; Antiviral Agents; DNA-Directed DNA Polymerase; Female; Follow-Up Studies; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Mutation; Recurrence | 2004 |
Serum lamivudine levels in the presence of a lamivudine-resistant HBV mutant.
Topics: Anti-HIV Agents; Chromatography, High Pressure Liquid; Drug Resistance, Viral; Enzyme-Linked Immunosorbent Assay; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Mutation; Polymerase Chain Reaction; Recurrence | 2004 |
Adefovir dipivoxil as the rescue therapy for lamivudine-resistant hepatitis B post liver transplant.
Topics: Adenine; Adolescent; Adult; Aged; Antiviral Agents; Child; Drug Resistance; Follow-Up Studies; Hepatitis B; Humans; Lamivudine; Liver Transplantation; Middle Aged; Organophosphonates; Postoperative Complications; Recurrence; Retrospective Studies | 2004 |
Prevention of hepatitis B virus recurrence after living donor liver transplantation.
Topics: Antiviral Agents; DNA, Viral; Hepatitis B; Humans; Lamivudine; Liver Transplantation; Living Donors; Preoperative Care; Recurrence; Retrospective Studies; RNA, Viral; Viral Load | 2004 |
Adefovir treatment in posttransplant hepatitis B virus infection resistant to lamivudine plus hepatitis B virus immunoglobulin.
Topics: Adenine; Adult; Antibodies, Viral; Antiviral Agents; Drug Resistance; Female; Hepatitis B; Hepatitis B Antibodies; Humans; Lamivudine; Living Donors; Male; Middle Aged; Organophosphonates; Recurrence | 2004 |
No hepatitis recurrence using combination prophylaxis in HBV-positive liver transplant recipients with YMDD mutants.
Topics: Adult; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Hepatitis B; Hepatitis B Antibodies; Hepatitis B virus; Humans; Immunosuppressive Agents; Lamivudine; Liver Transplantation; Male; Middle Aged; Mutation; Prospective Studies; Recurrence | 2005 |
[Liver transplantation finally available also for our patients with chronic hepatitis B virus infection].
Topics: Antiviral Agents; Hepatitis B, Chronic; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Cirrhosis; Liver Transplantation; Recurrence | 2004 |
[Liver transplantation for chronic hepatitis B].
Topics: Antiviral Agents; Hepatitis B, Chronic; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Cirrhosis; Liver Transplantation; Recurrence | 2004 |
Lamivudine monotherapy for spontaneous severe acute exacerbation of chronic hepatitis B.
Topics: Acute Disease; Administration, Oral; Adult; Bilirubin; Biomarkers; Disease Progression; DNA, Viral; Female; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver; Liver Failure, Acute; Male; Middle Aged; Prognosis; Radiography; Recurrence; Retrospective Studies; Reverse Transcriptase Inhibitors; Severity of Illness Index; Transaminases; Treatment Outcome; Ultrasonography | 2005 |
Viral load at the time of liver transplantation and risk of hepatitis B virus recurrence.
Topics: Adult; Antiviral Agents; Female; Hepatitis B; Hepatitis B virus; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Recurrence; Viral Load | 2005 |
[Therapeutic effect of adefovir dipivoxil on recurrent or de novo infection of hepatitis B virus after liver transplantation: a preliminary report].
Topics: Adenine; Adult; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis B, Chronic; Humans; Lamivudine; Liver Transplantation; Male; Middle Aged; Organophosphonates; Recurrence; Reverse Transcriptase Inhibitors | 2005 |
[HBV-specific CD8+ T cells for sustained HBeAg seroconversion after lamivudine therapy].
Topics: Adult; Antiviral Agents; CD8-Positive T-Lymphocytes; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Male; Recurrence; Viral Load | 2005 |
Virological and biochemical relapse after discontinuation of lamivudine monotherapy for chronic hepatitis B in Japan: comparison with breakthrough hepatitis during long-term treatment.
Topics: Adult; Aged; Alanine Transaminase; Antiviral Agents; Bilirubin; Female; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Japan; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Mutation; Promoter Regions, Genetic; Recurrence; Retrospective Studies; Risk Factors; Treatment Outcome | 2005 |
[Meningeal cryptococcosis as a sign of immune reconstitution syndrome].
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Anti-HIV Agents; Antifungal Agents; Antiretroviral Therapy, Highly Active; CD4-Positive T-Lymphocytes; Fluconazole; Flucytosine; HIV Infections; Humans; Immunologic Memory; Lamivudine; Lopinavir; Male; Meningitis, Cryptococcal; Pyrimidinones; Recurrence; Ritonavir; Syndrome; T-Lymphocyte Subsets; Zidovudine | 2005 |
Recurrence of post-traumatic stress disorder and antiretrovirals.
Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; CD4-Positive T-Lymphocytes; Cyclopropanes; Female; HIV Infections; HIV-1; Humans; Lamivudine; Oxazines; Recurrence; RNA, Viral; Stress Disorders, Post-Traumatic; Viral Load; Zidovudine | 2005 |
Reactivation of hepatitis B in an HIV-infected patient with antibodies against hepatitis B core antigen as the only serological marker.
Topics: Adult; Alanine Transaminase; Anti-HIV Agents; Aspartate Aminotransferases; Biomarkers; DNA, Viral; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; HIV Infections; Humans; Lamivudine; Male; Recurrence | 2005 |
Long-term results of lamivudine monotherapy in Korean patients with HBeAg-positive chronic hepatitis B: response and relapse rates, and factors related to durability of HBeAg seroconversion.
Topics: Adult; Age Factors; Aged; Alanine Transaminase; Antiviral Agents; DNA, Viral; Female; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Korea; Lamivudine; Male; Middle Aged; Recurrence; Retrospective Studies; Reverse Transcriptase Inhibitors; Risk Factors; Time Factors; Treatment Outcome | 2005 |
Polymerase domain B mutation is associated with hepatitis relapse during long-term lamivudine therapy for chronic hepatitis B.
Topics: Adult; Amino Acid Substitution; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Female; Gene Products, pol; Hepatitis B virus; Hepatitis B, Chronic; Humans; Japan; Lamivudine; Male; Middle Aged; Mutation, Missense; Predictive Value of Tests; Protein Structure, Tertiary; Recurrence; RNA-Directed DNA Polymerase | 2005 |
[Adefovir dipivoxil in treatment of decompensated liver cirrhosis patients with YMDD mutation].
Topics: Adenine; Adult; Aged; Amino Acid Motifs; Antiviral Agents; DNA-Directed DNA Polymerase; Female; Hepatic Encephalopathy; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Mutation; Organophosphonates; Protein Structure, Tertiary; Recurrence; Reverse Transcription | 2005 |
Adefovir added to lamivudine for hepatitis B recurrent infection in refractory B-cell chronic lymphocytic leukemia on prolonged therapy with Campath-1H.
Topics: Adenine; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Agents; Antiviral Agents; Drug Therapy, Combination; Hepatitis B; Humans; Lamivudine; Leukemia, Lymphocytic, Chronic, B-Cell; Organophosphonates; Recurrence; Treatment Outcome | 2006 |
Factors related to post-treatment relapse in chronic hepatitis B patients who lost HBeAg after lamivudine therapy.
Topics: Adult; Antiviral Agents; Chi-Square Distribution; DNA, Viral; Female; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Korea; Lamivudine; Liver Function Tests; Male; Proportional Hazards Models; Recurrence; Retreatment; Risk Factors | 2005 |
Study on the efficacy and safety of adefovir dipivoxil treatment in post-liver transplant patients with hepatitis B virus infection and lamivudine-resistant hepatitis B virus.
Topics: Adenine; Alanine Transaminase; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis C; Humans; Lamivudine; Liver Transplantation; Male; Organophosphonates; Recurrence; Retrospective Studies; Safety | 2005 |
Adefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutants.
Topics: Adenine; Adult; DNA, Viral; Drug Resistance, Viral; Follow-Up Studies; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis, Autoimmune; Humans; Lamivudine; Liver Transplantation; Male; Mutation; Organophosphonates; Recurrence; Reverse Transcriptase Inhibitors | 2006 |
Correlation of antiviral T-cell responses with suppression of viral rebound in chronic hepatitis B carriers: a proof-of-concept study.
Topics: Adult; Antiviral Agents; Combined Modality Therapy; Female; Genetic Engineering; Genetic Therapy; Hepatitis B Vaccines; Hepatitis B virus; Hepatitis B, Chronic; Heterozygote; Humans; Immunologic Memory; Interferon-gamma; Interleukin-12; Lamivudine; Male; Middle Aged; Recurrence; T-Lymphocytes; Vaccines, DNA; Virus Replication | 2006 |
Lamivudine therapy in kidney allograft recipients who are seropositive for hepatitis B surface antigen.
Topics: Antiviral Agents; DNA, Viral; Hepatitis B; Hepatitis B Surface Antigens; Humans; Kidney Transplantation; Lamivudine; Polymerase Chain Reaction; Recurrence; Retrospective Studies | 2006 |
Prophylactic use of low-dose, on-demand, intramuscular hepatitis B immunoglobulin and lamivudine after liver transplantation.
Topics: Antiviral Agents; DNA, Viral; Drug Administration Schedule; Follow-Up Studies; Hepatitis B; Hepatitis B virus; Humans; Immunoglobulins; Immunosuppressive Agents; Lamivudine; Liver Failure; Liver Transplantation; Recurrence; Retrospective Studies; Time Factors | 2006 |
Early reduction of infected hepatocytes by activated immunity at the time of interferon withdrawal hepatitis followed by lamivudine administration resulted in higher seroconversion in hepatitis Be antigen-positive patients with chronic hepatitis B.
Topics: Adult; Drug Resistance; Female; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Humans; Interferons; Lamivudine; Male; Mutation; Recurrence; Substance Withdrawal Syndrome | 2006 |
Prophylactic strategies for hepatitis B patients undergoing liver transplant: a cost-effectiveness analysis.
Topics: Adenine; Adult; Aged; Antiviral Agents; Cost-Benefit Analysis; Drug Therapy, Combination; Health Care Costs; Hepatitis B; Humans; Immunoglobulins; Lamivudine; Markov Chains; Middle Aged; Organophosphonates; Recurrence | 2006 |
[Hepatitis B virus reactivation after cessation of prophylaxis with lamivudine in a patient with non-Hodgkins lymphoma treated with chemotherapy and rituximab].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Female; Hepatitis B; Hepatitis B Antigens; Humans; Lamivudine; Lymphoma, Non-Hodgkin; Middle Aged; Recurrence; Reverse Transcriptase Inhibitors; Rituximab; Virus Activation | 2006 |
Biochemical response to lamivudine treatment in HBeAg negative chronic hepatitis B patients in Iran.
Topics: Adolescent; Adult; Aged; Alanine Transaminase; Aspartate Aminotransferases; Child; DNA, Viral; Dose-Response Relationship, Drug; Female; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Iran; Lamivudine; Male; Middle Aged; Recurrence; Retrospective Studies; Reverse Transcriptase Inhibitors | 2006 |
Outcomes of hepatitis B virus recurrence after liver transplantation.
Topics: Antiviral Agents; DNA, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Function Tests; Liver Transplantation; Recurrence; Retrospective Studies; Time Factors | 2006 |
Beneficial effects of short-term lamivudine treatment for de novo hepatitis B virus reactivation after liver transplantation.
Topics: Adolescent; Adult; Child; Child, Preschool; Female; Hepatitis B; Humans; Lamivudine; Liver Transplantation; Male; Recurrence; Retrospective Studies; Reverse Transcriptase Inhibitors; Treatment Outcome | 2006 |
Successful treatment with adefovir of one patient whose cryoglobulinemic vasculitis relapsed under lamivudine therapy and who was diagnosed to have HBV virologic breakthrough with YMDD mutations.
Topics: Adenine; Amino Acid Motifs; Aspartic Acid; Cryoglobulinemia; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Methionine; Middle Aged; Mutation; Organophosphonates; Recurrence; Tyrosine; Vasculitis | 2006 |
Recurrence of hepatitis B is associated with cumulative corticosteroid dose and chemotherapy against hepatocellular carcinoma recurrence after liver transplantation.
Topics: Adrenal Cortex Hormones; Adult; Antineoplastic Agents; Carcinoma, Hepatocellular; Dose-Response Relationship, Drug; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Neoplasm Recurrence, Local; Recurrence; Retrospective Studies; Risk Factors | 2007 |
Prophylaxis of recurrent hepatitis B in Chinese patients after liver transplantation using lamivudine combined with hepatitis B immune globulin according to the titer of antibody to hepatitis B surface antigen.
Topics: Adult; China; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins; Immunosuppressive Agents; Lamivudine; Liver Transplantation; Male; Middle Aged; Recurrence; Retrospective Studies; Survival Analysis | 2007 |
Prophylaxis of hepatitis B recurrence in post-liver transplantation patients with lamivudine-resistant YMDD mutant.
Topics: Adenine; Adult; Aged; Antiviral Agents; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Hepatitis B; Humans; Lamivudine; Liver Transplantation; Male; Middle Aged; Mutation; Organophosphonates; Recurrence | 2007 |
Efficacy of antiviral therapy with lamivudine after initial treatment for hepatitis B virus-related hepatocellular carcinoma.
Topics: Aged; Antiviral Agents; Carcinoma, Hepatocellular; Catheter Ablation; DNA, Viral; Female; Follow-Up Studies; Hepatectomy; Hepatitis B virus; Hepatitis B, Chronic; Humans; Japan; Kaplan-Meier Estimate; Lamivudine; Liver Neoplasms; Male; Middle Aged; Mutation; Recurrence; Retrospective Studies; Time Factors; Treatment Outcome | 2007 |
Preoperative lamivudine therapy in HBV DNA positive recipients: is it always necessary?
Topics: Adult; DNA, Viral; Female; Hepatitis B; Humans; Immunoglobulins; Immunosuppressive Agents; Lamivudine; Liver Transplantation; Male; Middle Aged; Models, Statistical; Recurrence; Treatment Outcome | 2007 |
Adefovir dipivoxil therapy in liver transplant recipients for recurrence of hepatitis B virus infection despite lamivudine plus hepatitis B immunoglobulin prophylaxis.
Topics: Adenine; Adult; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Organophosphonates; Recurrence; Serologic Tests | 2007 |
Antiviral prophylaxis and recurrence of hepatocellular carcinoma following liver transplantation in patients with hepatitis B.
Topics: Analysis of Variance; Antiviral Agents; Carcinoma, Hepatocellular; Disease-Free Survival; Hepatitis B; Humans; Immunoglobulins; Lamivudine; Liver Neoplasms; Neoplasm Staging; Postoperative Complications; Recurrence; Retrospective Studies; Survival Analysis; Survivors; Time Factors; Virus Diseases | 2007 |
The effectiveness of lamivudine in preventing hepatitis B viral reactivation in rituximab-containing regimen for lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; DNA, Viral; Female; Hepatitis B; Humans; Lamivudine; Lymphoma; Male; Middle Aged; Recurrence; Rituximab; Salvage Therapy; Virus Activation | 2008 |
[A study on mutations of the overlapping hepatitis B virus surface and polymerase gene in patients with HBV reinfection after liver transplantations].
Topics: Adult; Female; Gene Frequency; Genome, Viral; Genotype; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Mutation; Nested Genes; Recurrence | 2008 |
Hepatitis B reactivation after lamivudine.
Topics: Adult; Alanine Transaminase; Antiviral Agents; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Male; Prednisone; Recurrence; Virus Activation; Zalcitabine | 1995 |
Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo.
Topics: Adult; Antiviral Agents; Base Sequence; Conserved Sequence; DNA-Directed DNA Polymerase; Drug Resistance, Microbial; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Molecular Probes; Molecular Sequence Data; Mutation; Postoperative Complications; Recurrence; RNA, Viral; Viremia | 1996 |
Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation.
Topics: Antiviral Agents; DNA-Directed DNA Polymerase; DNA, Viral; Drug Resistance, Microbial; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Failure; Liver Transplantation; Male; Microbial Sensitivity Tests; Middle Aged; Point Mutation; Polymerase Chain Reaction; Recurrence | 1997 |
Beneficial effect of lamivudine in recurrent hepatitis B after liver transplantation.
Topics: Adult; Chronic Disease; Female; Hepatitis B; Humans; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Recurrence | 1997 |
[Preventive lamivudine against reinfection by hepatitis B after liver transplantation].
Topics: Follow-Up Studies; Hepatitis B; Hepatitis, Chronic; Humans; Lamivudine; Liver Transplantation; Postoperative Complications; Premedication; Recurrence; Reverse Transcriptase Inhibitors | 1997 |
The University of Toronto liver transplant program.
Topics: Adult; Alprostadil; Antiviral Agents; Child; Graft Survival; Hepatitis B; Hepatitis C; Hospitals, University; Humans; Immunization, Passive; Immunoglobulins; Immunosuppression Therapy; Lamivudine; Liver Neoplasms; Liver Transplantation; Ontario; Patient Selection; Recurrence; Retrospective Studies; Ribavirin; Survival Rate; Transplantation, Heterologous | 1996 |
Alteration of the dismal natural history of fibrosing cholestatic hepatitis secondary to hepatitis B virus with the use of lamivudine.
Topics: Antiviral Agents; Cholestasis, Intrahepatic; Diabetic Nephropathies; DNA, Viral; Graft Survival; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Kidney Failure, Chronic; Kidney Transplantation; Lamivudine; Liver; Liver Function Tests; Living Donors; Male; Middle Aged; Recurrence; Transplantation, Homologous; Virus Replication | 1997 |
thy/liv-SCID-hu mice: a system for investigating the in vivo effects of multidrug therapy on plasma viremia and human immunodeficiency virus replication in lymphoid tissues.
Topics: Animals; Anti-HIV Agents; Chronic Disease; Drug Resistance, Microbial; Drug Therapy, Combination; Fetal Tissue Transplantation; Flow Cytometry; HIV Infections; HIV-1; Lamivudine; Leukocytes, Mononuclear; Liver Transplantation; Mice; Mice, SCID; Recurrence; Ritonavir; RNA, Viral; Saquinavir; Thymus Gland; Viremia; Zidovudine | 1998 |
Postliver transplant allograft reinfection with a lamivudine-resistant strain of hepatitis B virus: long-term follow-up.
Topics: 2-Aminopurine; Adult; Antiviral Agents; Drug Resistance, Microbial; Famciclovir; Female; Follow-Up Studies; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Recurrence; Time Factors | 1998 |
[Prevention of hepatitis B--analysis of cost-effectiveness after liver transplantation].
Topics: 2-Aminopurine; Adult; Antiviral Agents; Cost-Benefit Analysis; Famciclovir; Female; Hepatitis B; Humans; Lamivudine; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Recurrence | 1997 |
Effectiveness of lamivudine in treatment of acute recurrent hepatitis B after liver transplantation.
Topics: Acute Disease; Bilirubin; DNA, Viral; Hepatitis B; Humans; Lamivudine; Liver Cirrhosis; Liver Transplantation; Postoperative Complications; Recurrence; Reverse Transcriptase Inhibitors; Transaminases | 1998 |
Successful treatment with lamivudine for fulminant reactivated hepatitis B infection following intensive therapy for high-grade non-Hodgkin's lymphoma.
Topics: Adult; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Carrier State; Fatal Outcome; Hepatitis B; Humans; Lamivudine; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Recurrence | 1998 |
Efficacy of lamivudine re-treatment in a patient with hepatitis B virus (HBV) recurrence after liver transplantation and HBV-DNA breakthrough during the first treatment.
Topics: Antiviral Agents; DNA, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Recurrence; Retreatment | 1998 |
Efficacy of lamivudine in controlling hepatitis B virus recurrence after liver transplantation.
Topics: Adult; Aged; Antiviral Agents; DNA, Viral; Female; Health Care Costs; Hepatitis B; Humans; Lamivudine; Liver Transplantation; Male; Middle Aged; Recurrence | 1998 |
Reactivation of hepatitis B in a long-term anti-HBs-positive patient with AIDS following lamivudine withdrawal.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; DNA, Viral; Drug Administration Schedule; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Homosexuality, Male; Humans; Lamivudine; Male; Middle Aged; Recurrence; Virus Activation | 1998 |
The sequential occurrence of viral mutations in a liver transplant recipient re-infected with hepatitis B: hepatitis B immune globulin escape, famciclovir non-response, followed by lamivudine resistance resulting in graft loss.
Topics: 2-Aminopurine; Amino Acid Sequence; Antiviral Agents; DNA-Directed DNA Polymerase; DNA, Viral; Drug Resistance; Famciclovir; Hepatitis B; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver; Liver Transplantation; Male; Middle Aged; Molecular Sequence Data; Mutation; Recurrence; Viral Proteins | 1998 |
Lamivudine treatment for acute hepatitis B after liver transplantation.
Topics: Acute Disease; Adult; Antiviral Agents; Female; Hepatitis B; Humans; Lamivudine; Liver Failure; Liver Transplantation; Male; Middle Aged; Recurrence | 1998 |
Efficacy of lamivudine in patients with hepatitis B virus precore mutant infection before and after liver transplantation.
Topics: Antiviral Agents; DNA, Viral; Drug Evaluation; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Liver Transplantation; Point Mutation; Recurrence; Virus Replication | 1999 |
Antiviral treatment for human immunodeficiency virus patients co-infected with hepatitis B virus: combined effect for both infections, an obtainable goal?
Topics: Anti-HIV Agents; DNA, Viral; Drug Resistance, Microbial; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Recurrence | 1999 |
Does Asian race affect hepatitis B virus recurrence or survival following liver transplantation for hepatitis B cirrhosis?
Topics: Adolescent; Adult; Asian People; Carcinoma, Hepatocellular; Hepatitis B; Hepatitis B e Antigens; Humans; Immunization, Passive; Immunoglobulins; Immunosuppression Therapy; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Methylprednisolone; Middle Aged; Recurrence; Reverse Transcriptase Inhibitors; Survival Rate | 1999 |
Mutational pattern of hepatitis B virus on sequential therapy with famciclovir and lamivudine in patients with hepatitis B virus reinfection occurring under HBIg immunoglobulin after liver transplantation.
Topics: 2-Aminopurine; Adult; Amino Acid Substitution; Antiviral Agents; DNA Primers; DNA-Directed DNA Polymerase; Famciclovir; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Methionine; Middle Aged; Point Mutation; Polymerase Chain Reaction; Prodrugs; Recurrence; Risk Factors; Valine | 1999 |
Association of lamivudine resistance in recurrent hepatitis B after liver transplantation with advanced hepatic fibrosis.
Topics: Adult; Anti-HIV Agents; DNA, Viral; Drug Resistance, Microbial; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Recurrence; Treatment Outcome | 1999 |
Chronic active hepatitis B exacerbations in human immunodeficiency virus-infected patients following development of resistance to or withdrawal of lamivudine.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Drug Resistance; Hepatitis B e Antigens; Hepatitis B, Chronic; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Recurrence; Retrospective Studies; Treatment Failure | 1999 |
Immunosuppression and reactivation of hepatitis B in the lamivudine era: opportunities for prevention and exploitation?
Topics: Antiviral Agents; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immune Tolerance; Lamivudine; Recurrence; Reverse Transcriptase Inhibitors; Virus Activation | 1999 |
Lamivudine therapy of hepatitis B virus-related liver disease: cirrhosis, posttransplantation recurrence, and de novo infection.
Topics: Adult; Aged; Female; Follow-Up Studies; Hepatitis B; Humans; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Recurrence; Reverse Transcriptase Inhibitors | 1999 |
Intramuscular hepatitis B immune globulin combined with lamivudine for prophylaxis against hepatitis B recurrence after liver transplantation.
Topics: Administration, Oral; DNA, Viral; Female; Follow-Up Studies; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunization, Passive; Immunoglobulins; Injections, Intramuscular; Lamivudine; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Recurrence; Reverse Transcriptase Inhibitors; Time Factors | 1999 |
Lamivudine therapy in patients undergoing liver transplantation for hepatitis B virus precore mutant-associated infection: high resistance rates in treatment of recurrence but universal prevention if used as prophylaxis with very low dose hepatitis B immu
Topics: Adult; Case-Control Studies; Female; Hepatitis B; Hepatitis B virus; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Polymerase Chain Reaction; Recurrence; Reverse Transcriptase Inhibitors; Viral Core Proteins | 1999 |
Lamivudine for hepatitis B in liver transplantation: a single-center experience.
Topics: Adult; Aged; DNA, Viral; Female; Follow-Up Studies; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Liver; Liver Transplantation; Longitudinal Studies; Male; Middle Aged; Postoperative Care; Postoperative Complications; Preoperative Care; Recurrence; Reverse Transcriptase Inhibitors; Virus Replication | 2000 |
Indications for liver transplantation in patients with chronic hepatitis B and C virus infection and hepatocellular carcinoma.
Topics: Antiviral Agents; Asia; Carcinoma, Hepatocellular; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Lamivudine; Liver Neoplasms; Liver Transplantation; Recurrence | 2000 |
Hepatitis B e antigen seroconversion after lamivudine therapy is not durable in patients with chronic hepatitis B in Korea.
Topics: Adult; Alanine Transaminase; DNA, Viral; Female; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Male; Middle Aged; Recurrence; Retrospective Studies; Reverse Transcriptase Inhibitors; Time Factors | 2000 |
Fatal hepatitis B reinfection after orthotopic liver transplantation in an HBsAg negative patient following withdrawal of lamivudine.
Topics: Antiviral Agents; Fatal Outcome; Female; Hepatitis B; Hepatitis B Surface Antigens; Humans; Lamivudine; Middle Aged; Postoperative Period; Recurrence | 2000 |
Exacerbation of hepatitis B infection following cessation of lamivudine therapy.
Topics: Adult; Anti-HIV Agents; Female; Hepatitis C, Chronic; HIV Infections; Humans; Lamivudine; Recurrence | 2000 |
[Therapy of recurrent hepatitis B infection after liver transplantation. A retrospective analysis of 200 liver transplantations based on hepatitis B associated liver diseases].
Topics: 2-Aminopurine; Adult; Antiviral Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Famciclovir; Female; Hepatitis B, Chronic; Humans; Immunization, Passive; Interferon alpha-2; Interferon-alpha; Lamivudine; Liver Transplantation; Male; Middle Aged; Recombinant Proteins; Recurrence; Retrospective Studies; Survival Rate; Treatment Outcome | 2000 |
Antiviral combination therapy for lamivudine-resistant hepatitis B reinfection after liver transplantation.
Topics: 2-Aminopurine; Alanine Transaminase; Antiviral Agents; DNA, Viral; Drug Resistance, Microbial; Drug Therapy, Combination; Famciclovir; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Liver Transplantation; Middle Aged; Postoperative Complications; Recombinant Proteins; Recurrence; Retrospective Studies; Time Factors; Virus Replication | 2000 |
Lamivudine improves the prognosis of patients with hepatitis B after liver transplantation.
Topics: 2-Aminopurine; Antiviral Agents; Famciclovir; Follow-Up Studies; Hepatitis B; Humans; Lamivudine; Liver Transplantation; Postoperative Complications; Prodrugs; Prognosis; Recurrence; Retrospective Studies; Time Factors; Treatment Failure; Treatment Outcome | 2000 |
Liver transplantation for patients with hepatitis B: prevention of hepatitis B recurrence by intravenous antihepatitis B immunoglobulin and lamivudine.
Topics: Adult; Antiviral Agents; Cyclosporine; Female; Follow-Up Studies; Hepatitis B; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Humans; Immunization, Passive; Immunoglobulins; Immunosuppressive Agents; Kidney Transplantation; Lamivudine; Liver Transplantation; Male; Middle Aged; Monitoring, Physiologic; Recurrence; Time Factors; Treatment Outcome | 2000 |
Prophylaxis against hepatitis B recurrence following liver transplantation in HBs Ag(+) patients.
Topics: Adult; Antiviral Agents; Cadaver; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B Surface Antigens; Humans; Immunization, Passive; Immunoglobulins; Immunosuppressive Agents; Lamivudine; Liver Transplantation; Living Donors; Male; Middle Aged; Recurrence; Retrospective Studies; Survival Rate; Tissue Donors | 2000 |
Lamivudine: a new strategy to suppress HBV replication in the pretransplant setting.
Topics: Adult; Antiviral Agents; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Transplantation; Middle Aged; Premedication; Recurrence; Virus Replication | 2000 |
From the food and drug administration.
Topics: Administrative Personnel; Anti-HIV Agents; Brachytherapy; Catheterization; Coronary Disease; Dideoxynucleosides; Drug Combinations; Equipment and Supplies; Humans; Lamivudine; Recurrence; Stents; Technology, Radiologic; United States; United States Food and Drug Administration; Zidovudine | 2001 |
Acute liver failure during lamivudine treatment in a hepatitis B cirrhotic patient.
Topics: Drug Administration Schedule; Fatal Outcome; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Liver Failure, Acute; Long-Term Care; Male; Middle Aged; Recurrence; Treatment Failure | 2001 |
Successful orthotopic liver transplantation.
Topics: Antiviral Agents; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Transplantation; Mutation; Recurrence | 2001 |
Severe clinical course of de novo hepatitis B infection after liver transplantation.
Topics: 2-Aminopurine; Adult; Antiviral Agents; Famciclovir; Fatal Outcome; Female; Hepatitis B; Humans; Lamivudine; Liver Transplantation; Middle Aged; Postoperative Complications; Recurrence; Reoperation; Retrospective Studies; Treatment Outcome | 2001 |
Liver transplantation in patients with hepatitis B virus infection: outcome in Asian versus white patients.
Topics: Antiviral Agents; Asia; Asian People; Drug Resistance; Female; Hepatitis B; Hepatitis C; Hepatitis D; Humans; Lamivudine; Liver Transplantation; Male; Middle Aged; Recurrence; Retrospective Studies; Survival Rate; Treatment Outcome; White People | 2001 |
A multicenter study of lamivudine treatment in 33 patients with hepatitis B after liver transplantation.
Topics: Adult; Aged; Alanine Transaminase; Antiviral Agents; DNA, Viral; Drug Resistance, Microbial; Female; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Transplantation; Male; Middle Aged; Prospective Studies; Recurrence; Safety | 2001 |
Lamivudine and low-dose hepatitis B immune globulin for prophylaxis of hepatitis B reinfection after liver transplantation possible role of mutations in the YMDD motif prior to transplantation as a risk factor for reinfection.
Topics: Adolescent; Adult; Amino Acid Motifs; Antiviral Agents; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Mutation; Recurrence; Risk Factors; Time Factors | 2001 |
Prevention of hepatitis B virus recurrence after liver transplantation in cirrhotic patients treated with lamivudine and passive immunoprophylaxis.
Topics: Adult; Antiviral Agents; DNA, Viral; Female; Hepatitis B; Hepatitis B Antibodies; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Recurrence | 2001 |
Hepatitis B virus variants in patients receiving lamivudine treatment with breakthrough hepatitis evaluated by serial viral loads and full-length viral sequences.
Topics: Adult; Alanine Transaminase; Amino Acid Motifs; Biological Evolution; Genetic Variation; Genome, Viral; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Open Reading Frames; Recurrence; Viral Load | 2001 |
Transient relapses ("blips") of plasma HIV RNA levels during HAART are associated with drug resistance.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; HIV; HIV Infections; Humans; Lamivudine; Mutation; Recurrence; Reverse Transcriptase Polymerase Chain Reaction; RNA, Viral; Viral Load | 2001 |
Preoperative antiviral treatment and postoperative prophylaxis in HBV-DNA positive patients undergoing liver transplantation.
Topics: 2-Aminopurine; Adult; Antiviral Agents; DNA, Viral; Famciclovir; Female; Hepatitis B; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Recurrence; Retrospective Studies | 2001 |
Prevention and treatment of hepatitis B relapse after liver transplantation.
Topics: Adult; Carcinoma, Hepatocellular; Female; Hepatitis B; Humans; Lamivudine; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Recurrence | 2001 |
Successful treatment with lamivudine for reactivated hepatitis B infection following chemotherapy for non-Hodgkin's lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Hepatitis B, Chronic; Humans; Lamivudine; Lymphoma, Non-Hodgkin; Male; Recurrence; Reverse Transcriptase Inhibitors | 2002 |
Lamivudine for the treatment of hepatitis B virus reactivation following chemotherapy for non-Hodgkin's lymphoma.
Topics: Acute Disease; Adult; Aged; Antiviral Agents; Female; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prospective Studies; Recurrence; Virus Activation | 2002 |
Recurrent hypersensitivity to Combivir.
Topics: Adult; Anti-HIV Agents; Drug Combinations; Drug Hypersensitivity; Female; HIV Infections; HIV-1; Humans; Lamivudine; Recurrence; Zidovudine | 2002 |
Lamivudine treatment for reverse seroconversion of hepatitis B 4 years after allogeneic bone marrow transplantation.
Topics: Adult; Antiviral Agents; Bone Marrow Transplantation; DNA, Viral; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Antigens; Humans; Immunosuppression Therapy; Lamivudine; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Recurrence; Time Factors; Transplantation, Homologous | 2002 |
Lamivudine treatment for recurrent pancreatitis associated with reactivation of chronic B hepatitis.
Topics: Acute Disease; Adult; Antiviral Agents; Hepatitis B, Chronic; Humans; Lamivudine; Male; Pancreatitis; Recurrence; Tomography, X-Ray Computed | 2002 |
New era of liver transplantation for hepatitis B: a 17-year single-center experience.
Topics: Antiviral Agents; Cause of Death; Cohort Studies; Disease-Free Survival; Female; Follow-Up Studies; Graft Survival; Hepatitis B, Chronic; Humans; Immunoglobulins; Immunosuppressive Agents; Lamivudine; Liver Transplantation; Male; Middle Aged; Multivariate Analysis; Recurrence; Retrospective Studies; Time Factors; Treatment Outcome | 2002 |
Effect of lamivudine treatment on survival of 309 North American patients awaiting liver transplantation for chronic hepatitis B.
Topics: Antiviral Agents; Female; Hepatitis B, Chronic; Humans; Lamivudine; Liver Transplantation; Male; Middle Aged; Recurrence; Retrospective Studies; Severity of Illness Index; Survival Analysis; Treatment Failure; Waiting Lists | 2002 |
Effect of virological response on post-treatment durability of lamivudine-induced HBeAg seroconversion.
Topics: Antiviral Agents; DNA, Viral; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Reagent Kits, Diagnostic; Recurrence; Retrospective Studies; Reverse Transcriptase Inhibitors; Sensitivity and Specificity | 2002 |
Safe use of livers from donors with positive hepatitis B core antibody.
Topics: Adolescent; Adult; Aged; Female; Hepatitis B; Hepatitis B Core Antigens; Humans; Immunosuppressive Agents; Lamivudine; Liver Transplantation; Male; Middle Aged; Recurrence; Tissue Donors | 2002 |
Impact of anti-hepatitis Bc-positive grafts on the outcome of liver transplantation for HBV-related cirrhosis.
Topics: Adult; Aged; Alkaline Phosphatase; Antiviral Agents; Disease-Free Survival; Female; Hepatitis B; Hepatitis B Core Antigens; Humans; Immunoglobulins; Lamivudine; Liver; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Recurrence; Retrospective Studies; Treatment Outcome | 2002 |
Course of virologic breakthroughs under long-term lamivudine in HBeAg-negative precore mutant HBV liver disease.
Topics: Adult; Aged; Alanine Transaminase; DNA, Viral; Drug Resistance, Viral; Female; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Kinetics; Lamivudine; Liver; Male; Middle Aged; Mutation; Polymerase Chain Reaction; Recurrence; Remission Induction; Viremia | 2002 |